archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO BLEB ASSEMBLY,3.3202e-07,1.6202,1.4362,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00022676,1.5121,1.2153,1,1
1,GO MEMBRANE RAFT ASSEMBLY,5.9841e-06,1.4257,1.5296,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,6.5896e-07,1.2317,1.0351,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,5.4977e-07,1.1931,1.0876,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00037661,1.1881,0.92433,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,5.7413e-06,1.1139,0.93694,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.6015e-06,1.1023,0.93513,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00026903,1.0756,0.99079,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,4.3763e-07,1.0692,0.99872,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.4692e-06,1.0451,0.88742,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,2.0033e-05,1.0386,0.93995,1,1
1,GO NEUTROPHIL HOMEOSTASIS,1.7118e-05,1.0288,0.89865,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,6.0198e-07,1.0286,0.99449,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.1788e-07,1.0272,1.0718,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00017186,1.0145,0.84865,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.6015e-06,1.0064,0.87657,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,1.2366e-07,0.99939,1.0143,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,2.3654e-06,0.98795,0.85679,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00045924,0.96203,0.71444,1,1
1,GO RESPONSE TO INTERFERON ALPHA,5.508e-06,0.94685,1.038,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.7474e-06,0.93268,0.93571,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.2971e-07,0.92007,0.89872,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00030804,0.90973,0.71503,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,1.2962e-05,0.90936,0.83235,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,6.2786e-05,0.90396,0.81338,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.1964e-05,0.89181,0.75812,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,0.00017186,0.8802,0.692,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,2.1831e-07,0.87942,0.83308,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.349e-05,0.87587,0.94636,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,1.7474e-06,0.86993,0.7984,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,1.2308e-06,0.86597,0.88208,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,4.1802e-07,0.86182,0.83025,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,5.0683e-06,0.85104,0.68467,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,2.6307e-05,0.84298,0.68034,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,4.4712e-06,0.84221,0.79417,1,1
1,GO MEMBRANE RAFT ORGANIZATION,2.7343e-05,0.83709,0.87857,1,1
1,GO CD40 SIGNALING PATHWAY,1.071e-07,0.82693,0.77987,1,1
1,GO RESPONSE TO INTERFERON BETA,5.2837e-06,0.81918,0.92851,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,6.5896e-07,0.81777,0.78008,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,3.0576e-06,0.81759,0.89986,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.6455e-05,0.80747,0.80426,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,2.6902e-06,0.80446,0.62773,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,4.1112e-06,0.80137,0.64678,1,1
1,GO ZYMOGEN INHIBITION,2.3975e-07,0.79652,0.83642,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,5.8301e-05,0.79399,0.72113,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.1831e-07,0.79033,0.76255,1,1
1,GO BONE TRABECULA FORMATION,0.00069957,0.78694,0.69894,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.1112e-06,0.78229,0.64479,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,1.0311e-06,0.78147,0.84883,1,1
1,GO PLASMINOGEN ACTIVATION,0.00050664,0.77909,0.5679,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.5816e-05,0.77206,0.634,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.5774e-06,0.76926,0.72213,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.4346e-05,0.76869,0.60576,1,1
1,GO HEMIDESMOSOME ASSEMBLY,0.00014935,0.7686,0.84322,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,3.4421e-05,0.76795,0.74319,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0001165,0.76685,0.59805,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00014418,0.76551,0.60018,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.1964e-05,0.76101,0.68517,1,1
1,GO ENDODERM FORMATION,1.8251e-06,0.76072,0.76315,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,2.2524e-05,0.75269,0.74878,1,1
1,GO HIPPO SIGNALING,7.9801e-06,0.75227,0.60477,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,7.5427e-07,0.75166,0.74589,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,3.9418e-06,0.74902,0.79355,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,3.4728e-06,0.74676,0.69154,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,9.0221e-07,0.74649,0.71766,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,7.5427e-07,0.74179,0.71117,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.4039e-05,0.73881,0.61619,1,1
1,GO LATERAL MESODERM DEVELOPMENT,1.1776e-06,0.73685,0.64433,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,8.1192e-05,0.73063,0.6161,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.2879e-07,0.72952,0.64617,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00014418,0.72155,0.53705,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,9.4334e-07,0.72044,0.68836,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,2.4515e-08,0.71993,0.73183,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.9263e-05,0.71488,0.59797,1,1
1,GO EPIBOLY,3.4728e-06,0.71392,0.72712,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.6015e-06,0.70893,0.66068,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00044439,0.70781,0.5479,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.0311e-06,0.70342,0.70039,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,3.6414e-07,0.70001,0.66337,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.0784e-06,0.69595,0.68242,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00079435,0.69499,0.65745,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,1.5691e-07,0.69195,0.68533,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00040247,0.687,0.59632,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00087311,0.68669,0.59062,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,6.0198e-07,0.68664,0.84149,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00098941,0.68562,0.59035,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,7.013e-05,0.68521,0.55664,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,9.389e-05,0.68327,0.52662,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,4.2876e-06,0.68038,0.54567,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,6.0504e-05,0.67994,0.65065,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,2.6902e-06,0.67893,0.60772,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,4.2876e-06,0.67808,0.58912,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.6455e-05,0.67638,0.60688,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.2862e-06,0.67234,0.71414,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,4.3218e-05,0.66933,0.63412,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,1.1776e-06,0.66879,0.67006,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00026003,0.664,0.53942,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.7118e-05,0.66063,0.6135,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.8521e-05,0.66014,0.47834,1,1
1,GO T CELL EXTRAVASATION,0.00012512,0.6594,0.59846,1,1
1,GO REGULATION OF PINOCYTOSIS,7.3528e-06,0.65699,0.65134,1,1
1,GO FIBRINOLYSIS,2.5308e-05,0.65363,0.749,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,9.3916e-06,0.65247,0.65644,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,1.4039e-05,0.64875,0.60191,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0011199,0.64802,0.49071,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00019079,0.64754,0.60079,1,1
1,GO GAP JUNCTION ASSEMBLY,2.2524e-05,0.64462,0.57288,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.4728e-06,0.63949,0.58867,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,1.1493e-05,0.63898,0.55196,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,7.2754e-05,0.63785,0.64678,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.001191,0.63741,0.55496,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,2.5774e-06,0.63346,0.69489,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,2.2524e-05,0.63193,0.59867,1,1
1,GO PIGMENT GRANULE MATURATION,7.0571e-06,0.63117,0.51482,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,1.4775e-08,0.62907,0.65251,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,2.5308e-05,0.62692,0.53022,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,7.9801e-06,0.62534,0.66645,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,6.7728e-06,0.62153,0.63482,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.4878e-05,0.62039,0.52377,1,1
1,GO ENDODERM DEVELOPMENT,3.6228e-06,0.61775,0.60691,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00057693,0.61669,0.68221,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.001872,0.61593,0.44551,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,3.6414e-07,0.61556,0.58403,1,1
1,GO DNA DEAMINATION,5.8301e-05,0.61555,0.57708,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00011241,0.61339,0.53799,1,1
1,GO VAGINA DEVELOPMENT,3.4728e-06,0.60935,0.62944,1,1
1,GO SNRNA PROCESSING,0.00026903,0.60934,0.62961,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,3.0689e-05,0.60729,0.46041,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,3.7145e-05,0.60628,0.64461,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,3.6228e-06,0.60537,0.54349,1,1
1,GO AMYLOID BETA CLEARANCE,4.1112e-06,0.60412,0.49412,1,1
1,GO VASCULOGENESIS,2.6322e-07,0.60346,0.5975,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,3.6228e-06,0.60224,0.63775,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,3.9926e-07,0.60223,0.63266,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,4.1112e-06,0.60153,0.55657,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.8521e-05,0.59994,0.64154,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,0.00013917,0.59955,0.56995,1,1
1,GO APOPTOTIC CELL CLEARANCE,4.6623e-06,0.59943,0.64568,1,1
1,GO LIVER REGENERATION,1.4963e-07,0.59611,0.57174,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,5.6174e-05,0.59606,0.46471,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.0604e-05,0.59458,0.52106,1,1
1,GO BIOLOGICAL PHASE,0.00029782,0.59458,0.58917,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,9.3916e-06,0.59451,0.49567,1,1
1,GO HEME METABOLIC PROCESS,1.0311e-06,0.59409,0.53592,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,8.6584e-06,0.5935,0.56045,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,1.2454e-05,0.59316,0.69237,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00010092,0.59284,0.53024,1,1
1,GO MUCUS SECRETION,0.0042883,0.58748,0.45427,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.8521e-05,0.58733,0.53668,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.00026903,0.58625,0.4806,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.2367e-06,0.58615,0.56166,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.1663e-05,0.58559,0.58815,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,4.8379e-05,0.58467,0.56573,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,4.6597e-05,0.58365,0.47072,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,5.8301e-05,0.58266,0.64745,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.9926e-07,0.58243,0.57181,1,1
1,GO NOTOCHORD DEVELOPMENT,4.8612e-06,0.58159,0.64331,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,3.9926e-07,0.57919,0.60013,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.4674e-06,0.57865,0.62976,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.7806e-05,0.57809,0.5874,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,9.0551e-05,0.57696,0.44772,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00019079,0.57539,0.58192,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.1776e-06,0.57534,0.47668,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,0.0001547,0.57413,0.54712,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,2.1663e-05,0.57348,0.60783,1,1
1,GO ENTRY INTO HOST,1.1776e-06,0.57198,0.56652,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.023741,0.57057,0.61,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00028792,0.57034,0.44902,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00016023,0.57033,0.50131,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,0.0001165,0.56878,0.45342,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.001191,0.56741,0.583,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,6.7596e-05,0.56622,0.52267,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,2.1831e-07,0.5628,0.63608,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,1.104e-05,0.55959,0.48757,1,1
1,GO CELLULAR RESPONSE TO DSRNA,2.8891e-07,0.557,0.5694,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,4.4878e-05,0.55695,0.49879,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7343e-05,0.55675,0.4552,1,1
1,GO SALIVARY GLAND DEVELOPMENT,4.6597e-05,0.55496,0.5346,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.6455e-05,0.55454,0.51078,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,4.8379e-05,0.55336,0.4899,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,3.7791e-06,0.55292,0.53515,1,1
1,GO TYPE 2 IMMUNE RESPONSE,1.104e-05,0.5506,0.53847,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,9.7346e-05,0.55056,0.42337,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00010845,0.55054,0.43884,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0081404,0.54968,0.36238,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.0194e-07,0.5495,0.64212,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.9841e-06,0.54924,0.54102,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,4.3218e-05,0.54867,0.4365,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.2862e-06,0.54697,0.49256,1,1
1,GO RESPONSE TO X RAY,1.1267e-06,0.54565,0.55991,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,1.4609e-05,0.54202,0.71784,1,1
1,GO REGULATION OF FIBRINOLYSIS,0.00044439,0.54138,0.53885,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0010528,0.54129,0.3874,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,9.0179e-06,0.53874,0.49731,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,6.0504e-05,0.53679,0.44202,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,4.5813e-07,0.53503,0.59445,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,4.0073e-05,0.53437,0.47802,1,1
1,GO CELLULAR RESPONSE TO IRON ION,0.00032948,0.53361,0.4715,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.7955e-07,0.53268,0.52592,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.7343e-05,0.53245,0.42421,1,1
1,GO COLLAGEN CATABOLIC PROCESS,4.1617e-05,0.53243,0.5315,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,6.4994e-06,0.53206,0.64628,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.0033e-05,0.53094,0.50441,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,2.3418e-05,0.53071,0.56613,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00010845,0.53069,0.44441,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.8612e-06,0.52768,0.53827,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00017186,0.52752,0.41241,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00055855,0.52599,0.38797,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,7.9801e-06,0.52439,0.47803,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.019283,0.52405,0.33231,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.3654e-06,0.5233,0.59314,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.6015e-06,0.52137,0.48725,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,6.7728e-06,0.52046,0.51356,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.4039e-05,0.52022,0.40962,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.7343e-05,0.51977,0.44476,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,6.4994e-06,0.51904,0.54062,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,7.2111e-07,0.51749,0.45706,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00025131,0.51714,0.42685,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.9263e-05,0.51677,0.42816,1,1
1,GO RESPONSE TO ANGIOTENSIN,2.5122e-07,0.51612,0.51129,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00026003,0.51606,0.56815,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00017796,0.51528,0.46398,1,1
1,GO VIRAL GENOME REPLICATION,9.7801e-06,0.51446,0.42498,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00069957,0.51399,0.46521,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,0.00011241,0.51359,0.4824,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.0022992,0.51218,0.63229,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.5201e-05,0.51198,0.58939,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,8.7323e-05,0.51114,0.44187,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0036303,0.51069,0.39203,1,1
1,GO TOLERANCE INDUCTION,0.00087311,0.51058,0.43682,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0016129,0.50826,0.43075,1,1
1,GO RESPONSE TO TYPE I INTERFERON,0.00022676,0.50777,0.56699,1,1
1,GO T CELL MEDIATED IMMUNITY,2.3418e-05,0.50749,0.43769,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,5.753e-07,0.50727,0.49158,1,1
1,GO CYTOLYSIS,3.8583e-05,0.50675,0.43174,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00057693,0.50574,0.46028,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,5.2139e-05,0.50512,0.65367,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,4.4878e-05,0.50369,0.46621,1,1
1,GO RESPONSE TO INTERFERON GAMMA,3.5759e-05,0.50278,0.47402,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00037661,0.50157,0.43081,1,1
1,GO GERMINAL CENTER FORMATION,0.00013917,0.50141,0.45343,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,3.9926e-07,0.50099,0.60456,1,1
1,GO NCRNA 3 END PROCESSING,0.0013872,0.50049,0.43331,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.4674e-06,0.49818,0.45041,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,9.0221e-07,0.49805,0.46082,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.0689e-05,0.49796,0.42433,1,1
1,GO SNRNA METABOLIC PROCESS,0.00010462,0.49715,0.50839,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,3.3132e-05,0.49586,0.40269,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,9.0179e-06,0.4958,0.45492,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00081984,0.49536,0.40238,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.906e-06,0.49515,0.46552,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0067808,0.49185,0.36805,1,1
1,GO MATURATION OF SSU RRNA,4.6597e-05,0.4915,0.40794,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0014738,0.49024,0.41457,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0022992,0.49021,0.40018,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,1.9263e-05,0.48967,0.42875,1,1
1,GO STORE OPERATED CALCIUM ENTRY,0.00012964,0.48967,0.3656,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,4.2876e-06,0.48924,0.42344,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,6.7596e-05,0.4887,0.43666,1,1
1,GO LEUKOCYTE AGGREGATION,0.0016129,0.48842,0.49307,1,1
1,GO AORTIC VALVE DEVELOPMENT,6.5149e-05,0.48841,0.43486,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,3.7791e-06,0.48734,0.45116,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00019753,0.48733,0.38337,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,5.0683e-06,0.48722,0.43493,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,3.3287e-06,0.4864,0.47088,1,1
1,GO PINOCYTOSIS,7.889e-07,0.48579,0.60371,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0017123,0.48507,0.45987,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00054072,0.48419,0.4515,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,4.4878e-05,0.48377,0.39176,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.00012074,0.48321,0.6634,1,1
1,GO REGULATION OF PROTEIN IMPORT,5.9841e-06,0.48268,0.39678,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00032948,0.48233,0.36686,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,2.5774e-06,0.48156,0.47655,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.00024286,0.48075,0.44886,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,6.6003e-08,0.48066,0.57887,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,5.2837e-06,0.48051,0.45805,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0029794,0.47825,0.31339,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00074557,0.47813,0.40552,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0013054,0.47791,0.43856,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00012964,0.47666,0.38126,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0022332,0.47626,0.36665,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.00098941,0.47561,0.34341,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,7.2754e-05,0.47557,0.58152,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,6.8936e-07,0.47554,0.40184,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.7118e-05,0.47553,0.39458,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,6.7596e-05,0.47511,0.44037,1,1
1,GO NIK NF KAPPAB SIGNALING,9.0221e-07,0.4751,0.408,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.1112e-06,0.47487,0.47495,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00044439,0.47433,0.40271,1,1
1,GO CYTOKINE METABOLIC PROCESS,2.6902e-06,0.47403,0.40927,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,3.1904e-06,0.47395,0.38615,1,1
1,GO VIRAL RNA GENOME REPLICATION,1.0779e-06,0.47388,0.43464,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00045924,0.47378,0.42782,1,1
1,GO BLOOD VESSEL REMODELING,9.389e-05,0.47255,0.41144,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.0779e-06,0.47243,0.4107,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0011199,0.4724,0.33737,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,1.7806e-05,0.47216,0.41134,1,1
1,GO HYALURONAN METABOLIC PROCESS,7.3528e-06,0.47151,0.47638,1,1
1,GO REGULATION OF TRANSPOSITION,0.00069957,0.47114,0.42458,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.016734,0.47047,0.38466,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00065623,0.46949,0.47953,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0010859,0.46929,0.37612,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,2.4346e-05,0.46886,0.42584,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.0833e-05,0.46844,0.46103,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,3.1904e-06,0.4684,0.5324,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,2.2524e-05,0.46838,0.6771,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,4.3763e-07,0.46825,0.43792,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,1.1267e-06,0.46814,0.48762,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.9904e-06,0.46744,0.49286,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00074557,0.46737,0.36764,1,1
1,GO REGULATION OF MYOBLAST FUSION,6.5149e-05,0.46731,0.53035,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,5.8301e-05,0.46682,0.44963,1,1
1,GO DEFENSE RESPONSE TO VIRUS,2.7343e-05,0.46678,0.40136,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,7.8282e-05,0.46674,0.41168,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,9.8628e-07,0.46666,0.49769,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.00010462,0.46661,0.39897,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.1493e-05,0.4665,0.39669,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0053338,0.46592,0.35163,1,1
1,GO MATURATION OF LSU RRNA,2.0833e-05,0.46526,0.49211,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0022332,0.46469,0.42308,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,5.8301e-05,0.46466,0.44721,1,1
1,GO RIG I SIGNALING PATHWAY,1.2862e-06,0.46367,0.43252,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.00010092,0.46339,0.48001,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,3.0576e-06,0.46315,0.40855,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0011549,0.46312,0.33122,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.3916e-06,0.46301,0.64739,1,1
1,GO REGULATION OF MRNA BINDING,3.4728e-06,0.4627,0.41962,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,8.6584e-06,0.46056,0.41563,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00047456,0.46034,0.44102,1,1
1,GO MACROPHAGE PROLIFERATION,0.00038934,0.46034,0.47275,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,3.4421e-05,0.4603,0.41892,1,1
1,GO RESPONSE TO HYPEROXIA,0.00090094,0.45959,0.41095,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.6623e-06,0.45935,0.44774,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00017186,0.4591,0.39432,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.4963e-07,0.45774,0.51664,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,7.6603e-06,0.45741,0.43839,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.0025083,0.45708,0.35969,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0059384,0.45687,0.35265,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.9263e-05,0.45677,0.39253,1,1
1,GO INTERLEUKIN 1 PRODUCTION,5.0226e-05,0.45668,0.44351,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,1.4039e-05,0.45662,0.39676,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.0571e-06,0.45629,0.43684,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,9.3916e-06,0.45535,0.35882,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,3.5759e-05,0.45515,0.45739,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.0032441,0.45446,0.55323,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.8891e-07,0.45439,0.3953,1,1
1,GO PROTEASOME ASSEMBLY,9.7801e-06,0.45437,0.36764,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,1.4674e-06,0.45382,0.44883,1,1
1,GO LYMPHANGIOGENESIS,2.0033e-05,0.45312,0.43975,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00025131,0.45282,0.45804,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00059588,0.45127,0.35528,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,5.4121e-05,0.45117,0.43552,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.7413e-06,0.45052,0.38183,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.010506,0.45033,0.3894,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.1112e-06,0.45007,0.38089,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,8.3127e-06,0.45002,0.4247,1,1
1,GO ZYMOGEN ACTIVATION,0.00012512,0.4498,0.4771,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00023468,0.44966,0.35812,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.3127e-06,0.44959,0.44345,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.0604e-05,0.44934,0.48788,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0054795,0.44865,0.29104,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00079435,0.4481,0.45429,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00022676,0.44657,0.48237,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,8.2505e-07,0.44643,0.45707,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00020448,0.44599,0.38733,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,1.2308e-06,0.44463,0.51205,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,6.7728e-06,0.44452,0.36042,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.2962e-05,0.44436,0.4276,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00036427,0.4436,0.37761,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00016595,0.44306,0.333,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,3.8583e-05,0.44299,0.44402,1,1
1,GO RETINAL METABOLIC PROCESS,0.0079323,0.44287,0.29179,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,9.8628e-07,0.44172,0.36568,1,1
1,GO PROTEIN ACTIVATION CASCADE,2.3418e-05,0.44166,0.36376,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,7.2754e-05,0.44164,0.40468,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,6.2367e-06,0.44108,0.52833,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.001191,0.44049,0.5116,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,1.5331e-06,0.44026,0.41809,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00021167,0.44006,0.34107,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,9.7801e-06,0.43934,0.41269,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,5.0683e-06,0.43912,0.44943,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.5691e-07,0.43909,0.41032,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.029068,0.43898,0.30724,1,1
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0013457,0.43786,0.51522,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,9.7346e-05,0.43709,0.41802,1,1
1,GO VIRAL TRANSLATION,1.8251e-06,0.4367,0.45906,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,6.7728e-06,0.4354,0.38808,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0031536,0.43402,0.43609,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,5.7413e-06,0.43381,0.44989,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,6.5149e-05,0.43316,0.4099,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.1237e-07,0.43302,0.43108,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,2.7343e-05,0.43292,0.46848,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,1.8521e-05,0.43268,0.46721,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00065623,0.43223,0.37355,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,1.0779e-06,0.43174,0.47339,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,9.7801e-06,0.43073,0.6137,1,1
1,GO PROTEIN OXIDATION,0.0032441,0.43055,0.40253,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,5.8301e-05,0.43033,0.51951,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,6.4994e-06,0.42981,0.49973,1,1
1,GO RECEPTOR CATABOLIC PROCESS,5.508e-06,0.42956,0.4221,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0007696,0.4288,0.39172,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00023468,0.42826,0.44396,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.2524e-05,0.42797,0.32924,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,2.6902e-06,0.42778,0.47662,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00044439,0.42753,0.48456,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,6.4994e-06,0.42744,0.36407,1,1
1,GO RIBOSOME ASSEMBLY,0.00021167,0.42689,0.37468,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0022332,0.42688,0.42052,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0018173,0.42541,0.34274,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0006154,0.4241,0.36921,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00055855,0.42338,0.38126,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0090226,0.42324,0.5363,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,2.2524e-05,0.42308,0.48312,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,2.0833e-05,0.42291,0.38304,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00025131,0.42232,0.36646,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,2.5308e-05,0.42213,0.4038,1,1
1,GO RESPONSE TO INTERLEUKIN 12,6.5896e-07,0.42189,0.42379,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0022992,0.42075,0.34714,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.00044439,0.42074,0.32798,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,1.7806e-05,0.42048,0.39044,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00010092,0.4201,0.37646,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.8251e-06,0.42009,0.41325,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,4.6623e-06,0.42008,0.40567,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.00044439,0.41998,0.34189,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,7.9801e-06,0.41993,0.3972,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00022676,0.41955,0.35959,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,1.8521e-05,0.41936,0.33443,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,0.00014935,0.41929,0.39297,1,1
1,GO VIRAL LIFE CYCLE,7.5427e-07,0.41928,0.4102,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,5.0683e-06,0.41924,0.43674,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00020448,0.41923,0.36091,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,1.8521e-05,0.41881,0.35474,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,5.508e-06,0.4188,0.38957,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,2.8418e-05,0.41838,0.44837,1,1
1,GO ANIMAL ORGAN REGENERATION,3.9418e-06,0.41819,0.45682,1,1
1,GO VASCULAR TRANSPORT,0.0045306,0.41798,0.50067,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00031859,0.41777,0.39554,1,1
1,GO ENAMEL MINERALIZATION,0.0010206,0.4175,0.41342,1,1
1,GO MULTI ORGANISM LOCALIZATION,5.4272e-08,0.41721,0.42193,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.001872,0.41712,0.29734,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00012964,0.41699,0.35853,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00012512,0.41699,0.34179,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.001986,0.41571,0.40466,1,1
1,GO DETECTION OF BIOTIC STIMULUS,0.00012512,0.41491,0.40793,1,1
1,GO REGULATION OF GASTRULATION,3.9418e-06,0.41456,0.38365,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,8.2505e-07,0.4132,0.39297,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00010092,0.41302,0.36691,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,0.0022992,0.41262,0.36339,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,2.9301e-06,0.41222,0.39318,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,6.5149e-05,0.41174,0.32491,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0029794,0.41154,0.39769,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00065623,0.41129,0.30028,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00017796,0.41096,0.32882,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0001547,0.41075,0.34247,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00050664,0.41069,0.35495,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.8077e-06,0.41033,0.40603,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.6455e-05,0.40945,0.43424,1,1
1,GO RESPONSE TO SALT STRESS,8.4205e-05,0.40877,0.34065,1,1
1,GO PLATELET AGGREGATION,1.6455e-05,0.40867,0.34724,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00010092,0.408,0.3803,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.00010845,0.40672,0.43017,1,1
1,GO IMMATURE T CELL PROLIFERATION,0.00030804,0.40543,0.41853,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.5201e-05,0.4044,0.46508,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00012964,0.40435,0.38109,1,1
1,GO INTERLEUKIN 17 PRODUCTION,7.3528e-06,0.40421,0.46191,1,1
1,GO I KAPPAB PHOSPHORYLATION,0.00032948,0.40407,0.26535,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00021909,0.40341,0.34853,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00017186,0.40267,0.41976,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,4.2876e-06,0.40259,0.37617,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,5.0226e-05,0.40239,0.44418,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,4.0073e-05,0.40234,0.41168,1,1
1,GO FIBROBLAST MIGRATION,8.1192e-05,0.40149,0.37003,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00021909,0.40134,0.3912,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,9.3916e-06,0.40129,0.38261,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0040578,0.40126,0.38794,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.6597e-05,0.40103,0.33629,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.02843,0.40083,0.25444,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,6.2367e-06,0.40039,0.37842,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,5.2533e-07,0.40003,0.36416,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00017796,0.39981,0.30696,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0025817,0.39931,0.36191,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0025083,0.3993,0.37941,1,1
1,GO REGULATION OF STEROL TRANSPORT,3.1888e-05,0.39811,0.32693,1,1
1,GO BONE GROWTH,0.00031859,0.39804,0.39085,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00010462,0.39785,0.36533,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00019753,0.39778,0.38013,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,1.5201e-05,0.39646,0.4831,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00057693,0.39633,0.41685,1,1
1,GO EMBRYO IMPLANTATION,5.2837e-06,0.3963,0.48212,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.0012662,0.39624,0.50316,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.001872,0.39525,0.36031,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,1.2454e-05,0.39518,0.3167,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,3.4728e-06,0.39436,0.4025,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.6623e-06,0.39421,0.40786,1,1
1,GO INTERFERON BETA PRODUCTION,0.00063551,0.39374,0.28077,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0007696,0.39367,0.42434,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.024846,0.39315,0.30733,1,1
1,GO B CELL MEDIATED IMMUNITY,1.1493e-05,0.39219,0.32883,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00035231,0.39213,0.3298,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.00050664,0.39208,0.2675,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,9.7801e-06,0.39202,0.4758,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00037661,0.39168,0.41576,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,4.8379e-05,0.39166,0.37296,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,1.6455e-05,0.39165,0.3247,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,3.5759e-05,0.39052,0.34348,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.00044439,0.3896,0.45233,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0024367,0.38956,0.43009,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0014299,0.38939,0.33139,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,7.2111e-07,0.38928,0.34999,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,1.6455e-05,0.3892,0.31423,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,9.389e-05,0.38866,0.35412,1,1
1,GO INTERACTION WITH HOST,1.2862e-06,0.38851,0.42151,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00081984,0.38813,0.3272,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,6.7596e-05,0.38754,0.32041,1,1
1,GO T CELL APOPTOTIC PROCESS,3.9418e-06,0.38743,0.35291,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.4205e-05,0.38686,0.37502,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,4.8379e-05,0.38665,0.35595,1,1
1,GO RESPONSE TO ESTROGEN,1.906e-06,0.38605,0.37828,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.4039e-05,0.38602,0.50865,1,1
1,GO INTERACTION WITH SYMBIONT,1.6455e-05,0.38551,0.32303,1,1
1,GO MUSCLE FILAMENT SLIDING,1.5816e-05,0.38506,0.37208,1,1
1,GO MATURATION OF 5 8S RRNA,9.0551e-05,0.38425,0.34519,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00021909,0.38396,0.32796,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0018173,0.38332,0.33369,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,4.0073e-05,0.38263,0.32592,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,5.2139e-05,0.38235,0.40799,1,1
1,GO PHAGOCYTOSIS RECOGNITION,0.00026003,0.38198,0.52252,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.014138,0.38137,0.29439,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.013139,0.38051,0.31178,1,1
1,GO SPROUTING ANGIOGENESIS,8.1192e-05,0.37991,0.32986,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,2.6902e-06,0.37824,0.3563,1,1
1,GO ERBB2 SIGNALING PATHWAY,0.00067758,0.37799,0.27711,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.4878e-05,0.37772,0.374,1,1
1,GO TYPE I INTERFERON PRODUCTION,2.9532e-05,0.37726,0.31876,1,1
1,GO MEMBRANE INVAGINATION,1.1964e-05,0.3772,0.34363,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00013433,0.37719,0.34546,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,9.0179e-06,0.37689,0.33822,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,0.00010092,0.37681,0.38157,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,9.7801e-06,0.37625,0.32835,1,1
1,GO INTERLEUKIN 8 PRODUCTION,3.8583e-05,0.37584,0.35701,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,6.5149e-05,0.37455,0.4064,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,3.8583e-05,0.37424,0.32107,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00031859,0.37418,0.34292,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,2.6307e-05,0.37373,0.35431,1,1
1,GO VIRAL GENE EXPRESSION,2.1663e-05,0.37334,0.37335,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0013872,0.3727,0.31583,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00041602,0.37259,0.29716,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,4.4712e-06,0.37124,0.3382,1,1
1,GO PLATELET DEGRANULATION,6.5149e-05,0.37045,0.40919,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.1964e-05,0.37029,0.3369,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.104e-05,0.36972,0.4647,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,9.0551e-05,0.36954,0.30813,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00021909,0.36932,0.35715,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00054072,0.36913,0.40699,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,2.2524e-05,0.36911,0.30422,1,1
1,GO MRNA TRANSCRIPTION,1.7806e-05,0.36896,0.36372,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1.349e-05,0.36865,0.3021,1,1
1,GO NCRNA PROCESSING,1.9263e-05,0.36771,0.31399,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,9.389e-05,0.36751,0.31504,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00087311,0.36675,0.27816,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00018427,0.36656,0.29641,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,3.1904e-06,0.36651,0.35304,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010092,0.366,0.31557,1,1
1,GO GLIAL CELL ACTIVATION,0.00044439,0.36566,0.32946,1,1
1,GO INTERLEUKIN 2 PRODUCTION,7.2111e-07,0.365,0.44177,1,1
1,GO FOREBRAIN MORPHOGENESIS,0.0087944,0.36376,0.22442,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.013465,0.36373,0.30771,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00031859,0.36363,0.29242,1,1
1,GO TRANSLATIONAL INITIATION,0.0001547,0.36348,0.33667,1,1
1,GO ERAD PATHWAY,7.9801e-06,0.36313,0.29582,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.1112e-06,0.36285,0.41149,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.8418e-05,0.36247,0.46318,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.4878e-05,0.36238,0.39757,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.001872,0.36203,0.27575,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,0.00010462,0.3613,0.39481,1,1
1,GO REGULATION OF COAGULATION,0.00037661,0.36015,0.36798,1,1
1,GO CRISTAE FORMATION,0.009256,0.35964,0.22802,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.001872,0.35953,0.31081,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0097392,0.35916,0.31665,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0014738,0.35888,0.33366,1,1
1,GO TRANSLATIONAL TERMINATION,0.00021909,0.35841,0.27093,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.35764,0.30135,1,1
1,GO FOCAL ADHESION ASSEMBLY,9.389e-05,0.35761,0.3785,1,1
1,GO RESPONSE TO VIRUS,1.7118e-05,0.35752,0.34657,1,1
1,GO NECROTIC CELL DEATH,4.0073e-05,0.35708,0.41609,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0017123,0.35682,0.32362,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4039e-05,0.35666,0.35925,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,9.0551e-05,0.35633,0.30813,1,1
1,GO RIBOSOME BIOGENESIS,7.2754e-05,0.35553,0.33104,1,1
1,GO FOREGUT MORPHOGENESIS,0.00010092,0.35543,0.40391,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.5331e-06,0.35527,0.37068,1,1
1,GO REGULATION OF PROTEIN MATURATION,5.2837e-06,0.35515,0.35968,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.011904,0.35505,0.37385,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0045306,0.35477,0.28039,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.00095906,0.35474,0.33324,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.3132e-05,0.35458,0.30128,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0071468,0.35426,0.27727,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.0226e-05,0.35415,0.32015,1,1
1,GO PEPTIDE CROSS LINKING,0.00024286,0.35394,0.44095,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,3.0689e-05,0.35382,0.38876,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,6.7728e-06,0.35336,0.36328,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,0.00027832,0.35331,0.39877,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.5691e-07,0.35322,0.36299,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0025083,0.35315,0.33665,1,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.041967,0.35312,0.2362,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00028792,0.35273,0.37725,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.0012662,0.35244,0.42826,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0025817,0.3522,0.34755,1,1
1,GO RESPONSE TO MANGANESE ION,5.9841e-06,0.3521,0.35651,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0069616,0.35204,0.41881,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.5149e-05,0.35188,0.37408,1,1
1,GO PIGMENT ACCUMULATION,0.00014935,0.35138,0.3236,1,1
1,GO NUCLEOSIDE SALVAGE,0.00041602,0.35108,0.44962,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00010462,0.35032,0.34502,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0016129,0.35017,0.33444,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00013433,0.35016,0.34299,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.00035231,0.34936,0.38277,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,3.4421e-05,0.3479,0.30679,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0024367,0.34778,0.42897,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0011549,0.34769,0.41889,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1663e-05,0.34748,0.34458,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00041602,0.34739,0.28186,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,3.1888e-05,0.34714,0.4747,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,6.5149e-05,0.3468,0.29437,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.3418e-05,0.34673,0.37001,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00065623,0.34661,0.28408,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00035231,0.34609,0.32,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00059588,0.34549,0.2292,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00021167,0.34546,0.29936,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00021909,0.34517,0.31159,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0079323,0.34493,0.37359,1,1
1,GO COPPER ION HOMEOSTASIS,7.3528e-06,0.34414,0.47299,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0017123,0.34412,0.30437,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00036427,0.34394,0.31658,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0031536,0.34378,0.31795,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.026586,0.34296,0.21288,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00063551,0.3429,0.28975,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00036427,0.34215,0.3514,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00016023,0.34205,0.44895,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.004408,0.342,0.35147,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00010092,0.34182,0.31229,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.6584e-06,0.3417,0.37157,1,1
1,GO RRNA METABOLIC PROCESS,9.7346e-05,0.34139,0.31154,1,1
1,GO VESICLE CARGO LOADING,1.0184e-05,0.34124,0.32875,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,6.5149e-05,0.34108,0.34714,1,1
1,GO REGULATION OF PROTEIN FOLDING,1.349e-05,0.34102,0.29653,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00052342,0.34086,0.31719,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,0.00012512,0.34081,0.36769,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.7145e-05,0.34062,0.36262,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.044685,0.34037,0.22614,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.012508,0.34035,0.38193,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0042883,0.34012,0.38318,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0067808,0.33982,0.22188,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,5.0226e-05,0.33981,0.3449,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0020453,0.33913,0.39154,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00079435,0.33911,0.35645,1,1
1,GO GASTRULATION,8.3127e-06,0.33885,0.34095,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.0020453,0.33884,0.44022,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00013433,0.3383,0.36183,1,1
1,GO L GLUTAMATE IMPORT,0.011904,0.33789,0.23794,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.6307e-05,0.33751,0.30925,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.7728e-06,0.33746,0.29111,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.0184e-05,0.33709,0.34037,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,3.0576e-06,0.33696,0.30074,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00012964,0.33696,0.30077,1,1
1,GO NATURAL KILLER CELL ACTIVATION,6.2786e-05,0.33686,0.30309,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0021689,0.33646,0.29674,1,1
1,GO PEPTIDE CATABOLIC PROCESS,0.00031859,0.33642,0.25182,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,4.3763e-07,0.33631,0.35125,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0053338,0.33596,0.3458,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00016023,0.33586,0.43706,1,1
1,GO T CELL MIGRATION,0.00031859,0.33584,0.2843,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,2.5774e-06,0.33546,0.31614,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0017641,0.33538,0.27665,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.001228,0.33513,0.49182,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,1.349e-05,0.3351,0.30251,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,8.6584e-06,0.33454,0.39701,1,1
1,GO REGULATION OF PHAGOCYTOSIS,2.7343e-05,0.33447,0.3496,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.8521e-05,0.33393,0.31592,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,9.0551e-05,0.33321,0.40098,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00037661,0.33299,0.33483,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,3.0576e-06,0.33284,0.29285,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.03939,0.33189,0.32363,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,3.7145e-05,0.33161,0.31189,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0014738,0.33142,0.22507,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,8.1192e-05,0.33137,0.43228,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0046564,0.33107,0.2759,1,1
1,GO CELL SUBSTRATE ADHESION,7.013e-05,0.3306,0.35529,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00044439,0.33058,0.35979,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00017186,0.33042,0.27253,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.010773,0.33037,0.249,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,4.4878e-05,0.33019,0.26141,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.00014418,0.33016,0.26449,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0087944,0.32948,0.27029,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.2754e-05,0.32926,0.27009,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00084609,0.32925,0.24506,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0001547,0.32914,0.36132,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0012662,0.32853,0.22627,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0022332,0.32836,0.38187,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0036303,0.32832,0.27256,1,1
1,GO NCRNA METABOLIC PROCESS,3.7145e-05,0.32832,0.27727,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0014738,0.32812,0.36675,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0097392,0.32801,0.43638,1,1
1,GO MESODERM MORPHOGENESIS,3.1904e-06,0.32796,0.33556,1,1
1,GO PIGMENT METABOLIC PROCESS,1.0604e-05,0.32794,0.30317,1,1
1,GO RRNA MODIFICATION,0.00098941,0.32772,0.25175,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,1.0184e-05,0.32756,0.39456,1,1
1,GO PORE COMPLEX ASSEMBLY,0.00023468,0.32744,0.25747,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00040247,0.327,0.31335,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,2.6307e-05,0.32676,0.4432,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00027832,0.32674,0.29963,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,5.508e-06,0.32652,0.3365,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,7.013e-05,0.32596,0.35476,1,1
1,GO PRIMARY MIRNA PROCESSING,0.00018427,0.32507,0.36277,1,1
1,GO OSTEOCLAST DEVELOPMENT,9.7346e-05,0.32501,0.37156,1,1
1,GO ASYMMETRIC CELL DIVISION,0.00055855,0.32482,0.27799,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00012964,0.32438,0.22331,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00027832,0.32436,0.30495,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.036164,0.32433,0.31728,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,2.9532e-05,0.32429,0.29696,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00081984,0.32418,0.29148,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,6.7596e-05,0.32349,0.26391,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00040247,0.32317,0.24641,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00072223,0.32296,0.33336,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00013433,0.32287,0.34038,1,1
1,GO RNA 5 END PROCESSING,0.00023468,0.3228,0.29001,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00020448,0.32259,0.29729,1,1
1,GO REGULATION OF RNA BINDING,2.2658e-06,0.32229,0.32505,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00014418,0.32219,0.29461,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00026903,0.32185,0.37518,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00016595,0.32183,0.34124,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.001872,0.32181,0.22191,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.025414,0.32172,0.25334,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.547e-05,0.32138,0.28275,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0046564,0.32056,0.21248,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.00040247,0.31984,0.24768,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00065623,0.31974,0.24316,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,6.2786e-05,0.31957,0.29793,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.1904e-06,0.31922,0.30548,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00038934,0.31884,0.32061,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,3.9418e-06,0.31874,0.32723,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,7.013e-05,0.31863,0.32192,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.0020453,0.31854,0.33882,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00027832,0.31836,0.30263,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00016023,0.31827,0.28117,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0038387,0.31825,0.25315,1,1
1,GO HISTONE PHOSPHORYLATION,6.2367e-06,0.31819,0.28825,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.0576e-06,0.31788,0.33809,1,1
1,GO REGENERATION,3.4421e-05,0.3173,0.26578,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00052342,0.3167,0.25541,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0042883,0.31647,0.2907,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00037661,0.3157,0.30648,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00012964,0.31539,0.3084,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0017641,0.31524,0.31348,1,1
1,GO CYTOKINETIC PROCESS,5.0226e-05,0.31522,0.2914,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.011326,0.31514,0.267,1,1
1,GO CARNITINE METABOLIC PROCESS,0.0090226,0.31511,0.2603,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0017123,0.31497,0.369,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,3.0689e-05,0.31482,0.3214,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,4.0073e-05,0.31461,0.29221,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.17e-07,0.3146,0.31144,1,1
1,GO INNATE IMMUNE RESPONSE,5.4121e-05,0.31441,0.25849,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,9.389e-05,0.31346,0.24364,1,1
1,GO GTP METABOLIC PROCESS,4.4878e-05,0.31281,0.3437,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.1888e-05,0.31274,0.3227,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00044439,0.3127,0.28942,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.00024286,0.31231,0.39086,1,1
1,GO PROTEIN DEGLYCOSYLATION,0.00050664,0.31185,0.30249,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,4.4878e-05,0.31153,0.36722,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0017123,0.31153,0.28443,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,6.7596e-05,0.31117,0.49981,1,1
1,GO CHONDROCYTE DIFFERENTIATION,0.00012512,0.3111,0.29046,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.00035231,0.311,0.26286,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.2962e-05,0.31063,0.26462,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.013798,0.31043,0.28174,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.0033e-05,0.31034,0.28811,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0010859,0.31017,0.29007,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.00010092,0.3093,0.26177,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.3418e-05,0.30918,0.28562,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00037661,0.30916,0.29875,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.004408,0.30896,0.27849,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00012512,0.30891,0.28361,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00024286,0.30883,0.29134,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,3.0689e-05,0.30811,0.33182,1,1
1,GO SYNCYTIUM FORMATION,0.00026903,0.30751,0.29671,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.3654e-06,0.30727,0.27588,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0021062,0.30708,0.29054,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00059588,0.30683,0.24751,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0007696,0.3067,0.32801,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0081404,0.30664,0.40992,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,1.6455e-05,0.30614,0.28907,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00011241,0.30587,0.28784,1,1
1,GO RESPONSE TO INTERLEUKIN 1,9.3916e-06,0.3052,0.33582,1,1
1,GO RESPONSE TO DSRNA,5.2837e-06,0.30518,0.357,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,4.1112e-06,0.30478,0.307,1,1
1,GO ASTROCYTE ACTIVATION,0.009256,0.30474,0.26639,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00055855,0.304,0.21165,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.4039e-05,0.30385,0.3325,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00012074,0.30376,0.32768,1,1
1,GO VASCULATURE DEVELOPMENT,8.1192e-05,0.30356,0.27492,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00098941,0.30355,0.22802,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.6623e-06,0.30344,0.22606,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0021689,0.30333,0.25674,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00026003,0.30326,0.36121,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.349e-05,0.30281,0.31593,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.2876e-06,0.30251,0.4298,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.3132e-05,0.30227,0.26097,1,1
1,GO MACROPHAGE MIGRATION,8.6584e-06,0.30081,0.34824,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,3.3132e-05,0.30068,0.27495,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0030654,0.30062,0.28397,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.012508,0.30021,0.2753,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,5.9841e-06,0.30003,0.30327,1,1
1,GO IRON ION HOMEOSTASIS,3.4728e-06,0.3,0.28187,1,1
1,GO T CELL CYTOKINE PRODUCTION,1.7806e-05,0.29996,0.39954,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.031059,0.29984,0.20422,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.0025083,0.2991,0.39088,1,1
1,GO FOAM CELL DIFFERENTIATION,0.0010528,0.29858,0.26572,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.026586,0.29851,0.19626,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0015653,0.29829,0.23703,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.007729,0.29822,0.31839,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.8521e-05,0.29803,0.29953,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00030804,0.29797,0.25484,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.00010092,0.29777,0.2841,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0034322,0.29761,0.29585,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,5.9841e-06,0.29746,0.36336,1,1
1,GO MUSCLE CELL PROLIFERATION,6.5149e-05,0.29704,0.28275,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0015653,0.29696,0.32067,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.00081984,0.2969,0.22919,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,7.013e-05,0.2969,0.32568,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0030654,0.29675,0.2405,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,5.2837e-06,0.2965,0.27684,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00026903,0.29629,0.25313,1,1
1,GO LYMPHOCYTE MIGRATION,0.00074557,0.29593,0.2144,1,1
1,GO RNA CATABOLIC PROCESS,5.2533e-07,0.29577,0.27618,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,7.013e-05,0.29573,0.36098,1,1
1,GO ENDOTHELIAL CELL MIGRATION,0.00016595,0.29565,0.29869,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00055855,0.29535,0.23187,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.4674e-06,0.29489,0.26295,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.2876e-06,0.2948,0.27316,1,1
1,GO SELECTIVE AUTOPHAGY,1.0779e-06,0.29472,0.30122,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,2.3418e-05,0.2947,0.29065,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.00069957,0.29467,0.3063,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.016734,0.29463,0.21143,1,1
1,GO REGULATION OF CELL AGING,5.753e-07,0.29407,0.32107,1,1
1,GO SPERM EGG RECOGNITION,3.3132e-05,0.29394,0.25072,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.010773,0.29392,0.27176,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,1.1493e-05,0.29328,0.25671,1,1
1,GO REPLICATIVE SENESCENCE,0.03939,0.29307,0.31363,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,7.2754e-05,0.29304,0.27968,1,1
1,GO T CELL CHEMOTAXIS,5.0226e-05,0.29304,0.26953,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.015203,0.29269,0.19349,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00012512,0.29263,0.2967,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,2.0833e-05,0.29254,0.28113,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0001165,0.29186,0.31895,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,2.5308e-05,0.29169,0.29962,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0017123,0.29166,0.25128,1,1
1,GO TRABECULA FORMATION,0.0010859,0.29145,0.39756,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0042883,0.29141,0.19981,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0036303,0.29116,0.25375,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00092958,0.2911,0.2366,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00036427,0.29105,0.3014,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.00087311,0.29091,0.22607,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,2.7343e-05,0.29086,0.35355,1,1
1,GO HYPOTONIC RESPONSE,0.0028957,0.29084,0.26058,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.017549,0.29056,0.24794,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00036427,0.29039,0.297,1,1
1,GO MYOBLAST DIFFERENTIATION,2.2524e-05,0.29037,0.30526,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.7806e-05,0.29034,0.29898,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.012203,0.29025,0.20024,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.019283,0.2901,0.26415,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00059588,0.29,0.23861,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00020448,0.28993,0.28785,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00014418,0.28974,0.29351,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00084609,0.28969,0.34745,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0037331,0.28912,0.2391,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00035231,0.28892,0.23726,1,1
1,GO GENITALIA MORPHOGENESIS,0.011326,0.28854,0.27539,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.0064317,0.28813,0.2952,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,6.7596e-05,0.28802,0.35661,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00031859,0.28779,0.29811,1,1
1,GO COPPER ION TRANSPORT,5.0226e-05,0.28722,0.31578,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,4.8612e-06,0.28707,0.26501,1,1
1,GO SYMBIOTIC PROCESS,3.8131e-07,0.28705,0.27734,1,1
1,GO CELLULAR RESPONSE TO VIRUS,2.3418e-05,0.28692,0.3008,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00013433,0.28677,0.25906,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.9418e-06,0.2864,0.31489,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00010462,0.28613,0.29907,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.00087311,0.28595,0.28378,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.0015189,0.28589,0.21591,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00032948,0.28566,0.28903,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00035231,0.28517,0.24906,1,1
1,GO PROSTATIC BUD FORMATION,0.017137,0.28454,0.28056,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00095906,0.28453,0.24182,1,1
1,GO RESPONSE TO PROTOZOAN,0.00065623,0.28426,0.29333,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,0.0016129,0.2842,0.29603,1,1
1,GO CELL CELL RECOGNITION,3.6228e-06,0.28408,0.28387,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,3.6228e-06,0.28401,0.26342,1,1
1,GO STEROL TRANSPORT,0.00065623,0.28389,0.2131,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,5.8301e-05,0.2838,0.24879,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.0779e-06,0.28314,0.23966,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,3.1888e-05,0.28304,0.21758,1,1
1,GO TISSUE REGENERATION,0.0010528,0.28297,0.25017,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.0013457,0.28287,0.33924,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0083534,0.28279,0.28619,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,0.00065623,0.28245,0.31385,1,1
1,GO RESPONSE TO CYTOKINE,4.0073e-05,0.28227,0.28033,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0033369,0.28227,0.22105,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00021167,0.28222,0.21241,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.6597e-05,0.2822,0.25978,1,1
1,GO GLAND MORPHOGENESIS,0.0006154,0.28194,0.33519,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.0021062,0.28171,0.27197,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0010859,0.28117,0.29364,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00074557,0.28092,0.26148,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0028141,0.28063,0.25498,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00017186,0.28031,0.20584,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0012662,0.28027,0.29063,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,9.7346e-05,0.2802,0.32528,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,4.1617e-05,0.28018,0.29791,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,0.00024286,0.27967,0.2344,1,1
1,GO CHOLESTEROL EFFLUX,0.00019079,0.27964,0.27133,1,1
1,GO EPOXYGENASE P450 PATHWAY,0.0071468,0.27946,0.24034,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0013457,0.27944,0.25378,1,1
1,GO MACROPHAGE DIFFERENTIATION,0.00012512,0.27938,0.34375,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,4.3218e-05,0.27927,0.37133,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0017641,0.27913,0.23424,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00038934,0.27881,0.24693,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00042998,0.27841,0.28363,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,6.7596e-05,0.27776,0.28694,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0059384,0.27774,0.23075,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0011549,0.2776,0.27757,1,1
1,GO DECIDUALIZATION,0.043763,0.27756,0.2536,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0020453,0.27753,0.26354,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0081404,0.27718,0.22394,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.4609e-05,0.27713,0.27498,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0013872,0.27711,0.2651,1,1
1,GO CARTILAGE DEVELOPMENT,0.00081984,0.27694,0.23381,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.00045924,0.27682,0.25115,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00050664,0.27652,0.26851,1,1
1,GO KERATINOCYTE MIGRATION,0.00030804,0.27652,0.28497,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00029782,0.2765,0.30265,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00049035,0.27596,0.24546,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.7791e-06,0.27592,0.33516,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00032948,0.27564,0.4147,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,4.4878e-05,0.27544,0.32869,1,1
1,GO PROTEIN FOLDING,3.1888e-05,0.27443,0.24277,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0018173,0.27424,0.33546,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,6.0504e-05,0.27378,0.21123,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0011199,0.27339,0.206,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.007729,0.27338,0.30936,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00022676,0.27331,0.34406,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00067758,0.27299,0.27558,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.042857,0.27261,0.17261,1,1
1,GO RESPONSE TO THYROID HORMONE,0.0014738,0.27259,0.27932,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0036303,0.27247,0.29946,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0010206,0.27196,0.22905,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00047456,0.27188,0.19685,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,2.4692e-06,0.27113,0.26617,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00029782,0.27082,0.22481,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00079435,0.2708,0.28541,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.0028141,0.27065,0.19187,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,9.8628e-07,0.27062,0.34518,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0007696,0.27056,0.36838,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.5201e-05,0.27044,0.23149,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.00017796,0.27043,0.29305,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.27041,0.29844,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00090094,0.2703,0.33266,1,1
1,GO ASTROCYTE DEVELOPMENT,0.0010528,0.26991,0.28498,1,1
1,GO PLATELET MORPHOGENESIS,0.00013433,0.2699,0.25265,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.011326,0.26967,0.20631,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00010462,0.26924,0.21331,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00092958,0.26909,0.31344,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00038934,0.26858,0.25206,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,5.8301e-05,0.26849,0.27635,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1663e-05,0.26815,0.27001,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0006154,0.26799,0.30609,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00052342,0.26793,0.23054,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0041716,0.26779,0.27589,1,1
1,GO RESPONSE TO IONIZING RADIATION,7.6603e-06,0.26769,0.25222,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0010206,0.26744,0.24688,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.7343e-05,0.2674,0.41269,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0045306,0.26713,0.19381,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.011326,0.26704,0.23334,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.2962e-05,0.26688,0.35118,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00019753,0.26676,0.23707,1,1
1,GO COMPLEMENT ACTIVATION,6.2786e-05,0.26652,0.27406,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0025083,0.26639,0.21033,1,1
1,GO MEMBRANE DISASSEMBLY,0.0031536,0.26613,0.25416,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,3.3132e-05,0.26597,0.22613,1,1
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0062634,0.26596,0.25532,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.001228,0.26579,0.34035,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00028792,0.26537,0.23284,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0022332,0.26525,0.26284,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0028141,0.26522,0.32015,1,1
1,GO SEQUESTERING OF METAL ION,0.004408,0.26461,0.17079,1,1
1,GO TRANSLATIONAL ELONGATION,0.00079435,0.2646,0.2174,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0017641,0.26387,0.22775,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00098941,0.26343,0.22671,1,1
1,GO IMMUNOGLOBULIN SECRETION,0.0054795,0.26333,0.26495,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.021165,0.26329,0.17077,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,5.4121e-05,0.26294,0.25865,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0024367,0.26284,0.25246,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00095906,0.2628,0.22473,1,1
1,GO VIRION ASSEMBLY,0.00041602,0.26279,0.19021,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00036427,0.26256,0.23135,1,1
1,GO MUSCLE CELL MIGRATION,0.02843,0.2624,0.21641,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.26204,0.27623,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0016129,0.26203,0.26202,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00031859,0.26192,0.21082,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0011549,0.26192,0.20924,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0017641,0.26161,0.24701,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00063551,0.26153,0.21144,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.007729,0.26127,0.23225,1,1
1,GO OSTEOBLAST DIFFERENTIATION,0.00042998,0.26112,0.24299,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.889e-07,0.26094,0.32356,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.0226e-05,0.2609,0.26072,1,1
1,GO DETECTION OF OTHER ORGANISM,0.024846,0.2608,0.2492,1,1
1,GO AUTOPHAGOSOME MATURATION,9.0551e-05,0.26078,0.25756,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,0.00016023,0.26053,0.28123,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1.6015e-06,0.26052,0.21883,1,1
1,GO RNA 3 END PROCESSING,2.3418e-05,0.26012,0.22782,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00041602,0.25986,0.21238,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.6307e-05,0.25973,0.27152,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0081404,0.25969,0.27515,1,1
1,GO RNA DESTABILIZATION,1.8521e-05,0.25959,0.25955,1,1
1,GO CHYLOMICRON ASSEMBLY,0.0037331,0.25909,0.24711,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.034637,0.25901,0.23514,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0025817,0.25898,0.2058,1,1
1,GO REGULATION OF GENE SILENCING,4.4712e-06,0.25818,0.24552,1,1
1,GO RESPONSE TO WOUNDING,0.00042998,0.25803,0.23589,1,1
1,GO WOUND HEALING,0.00030804,0.25787,0.28422,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,3.7791e-06,0.25786,0.23563,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.6307e-05,0.25781,0.24468,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00063551,0.25753,0.28387,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00040247,0.25725,0.23476,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,0.00072223,0.25665,0.29054,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00092958,0.25663,0.21933,1,1
1,GO TRNA 5 END PROCESSING,0.00034072,0.25637,0.28103,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00020448,0.25612,0.28211,1,1
1,GO CYTOKINE PRODUCTION,7.2754e-05,0.25584,0.24688,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0013457,0.25553,0.24421,1,1
1,GO FATTY ACID BETA OXIDATION,0.0014738,0.2554,0.22345,1,1
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.013139,0.25521,0.21637,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00018427,0.25502,0.24922,1,1
1,GO CELL MATRIX ADHESION,0.00049035,0.25483,0.29585,1,1
1,GO RRNA METHYLATION,0.0013054,0.25442,0.22038,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.00017796,0.25424,0.21558,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0021062,0.25378,0.3085,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00079435,0.25364,0.30822,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,1.5816e-05,0.25329,0.25871,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0057817,0.25311,0.36914,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.012203,0.25307,0.25641,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.0067808,0.25295,0.21204,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00017186,0.25285,0.22825,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0012662,0.25276,0.19364,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,3.8583e-05,0.25263,0.23772,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.6307e-05,0.25239,0.38341,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.011326,0.25197,0.25426,1,1
1,GO REGULATION OF HEART GROWTH,0.00025131,0.25195,0.22549,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00040247,0.25186,0.21884,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.0067808,0.25178,0.39619,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0023671,0.25097,0.26297,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0019282,0.2507,0.21949,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0024367,0.25035,0.15075,1,1
1,GO ERK1 AND ERK2 CASCADE,0.00010462,0.25018,0.21697,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0011199,0.24977,0.24929,1,1
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.0047853,0.24977,0.19343,1,1
1,GO REGULATION OF ORGAN GROWTH,3.6228e-06,0.24884,0.28813,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0036303,0.24872,0.23333,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.012203,0.2485,0.25704,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00018427,0.24849,0.21894,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,0.00041602,0.24839,0.26257,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00014935,0.2481,0.20636,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0042883,0.24808,0.16975,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,7.2754e-05,0.24783,0.27522,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00027832,0.24755,0.24645,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0016129,0.24749,0.23049,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.0604e-05,0.24744,0.23538,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,2.4346e-05,0.24713,0.23604,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.025414,0.24702,0.2113,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,2.0833e-05,0.24693,0.21822,1,1
1,GO TRNA PROCESSING,0.00035231,0.2469,0.19368,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,5.8301e-05,0.24675,0.24262,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.7118e-05,0.2467,0.32276,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0054795,0.24667,0.25172,1,1
1,GO GONADOTROPIN SECRETION,0.033894,0.24665,0.21891,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00095906,0.24648,0.25305,1,1
1,GO PODOSOME ASSEMBLY,0.00017186,0.24635,0.35559,1,1
1,GO IMMUNE EFFECTOR PROCESS,4.3218e-05,0.24623,0.26165,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00084609,0.24612,0.35889,1,1
1,GO COAGULATION,0.00030804,0.24564,0.25109,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.024288,0.24564,0.32111,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.001872,0.24453,0.16266,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.016339,0.24448,0.22779,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0025083,0.24447,0.24683,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,2.1663e-05,0.24446,0.2362,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,6.0504e-05,0.24432,0.23126,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.011047,0.24429,0.20124,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.0010859,0.24414,0.2383,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.8282e-05,0.24399,0.27417,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,9.0551e-05,0.24384,0.24487,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.010773,0.24382,0.16226,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00072223,0.24362,0.41633,1,1
1,GO TOXIN TRANSPORT,0.010245,0.2436,0.15713,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0010206,0.24348,0.20222,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0038387,0.24302,0.16385,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0027346,0.24271,0.27533,1,1
1,GO TISSUE REMODELING,0.0027346,0.24263,0.2242,1,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0097392,0.24249,0.16562,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0017641,0.24212,0.24638,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.00079435,0.24204,0.2362,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00029782,0.24163,0.24768,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00069957,0.24163,0.21713,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.015574,0.24161,0.15475,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00069957,0.24144,0.17645,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0042883,0.24137,0.22958,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00052342,0.24124,0.23102,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00020448,0.24123,0.22101,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.02268,0.2411,0.20412,1,1
1,GO RESPONSE TO PROGESTERONE,0.011904,0.24076,0.26244,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0036303,0.24042,0.1661,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.001228,0.24031,0.23036,1,1
1,GO PEPTIDE METABOLIC PROCESS,6.7728e-06,0.24018,0.21786,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00049035,0.24011,0.34328,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,6.5149e-05,0.23988,0.26456,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,4.8379e-05,0.23978,0.21154,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0028141,0.23959,0.20877,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0059384,0.23955,0.20892,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0030654,0.23946,0.23321,1,1
1,GO PHAGOCYTOSIS,2.0033e-05,0.23925,0.30249,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00025131,0.2392,0.24638,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.017137,0.23915,0.20685,1,1
1,GO RESPONSE TO CORTICOSTEROID,0.0011199,0.23905,0.21758,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,5.0226e-05,0.23898,0.23134,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00092958,0.23885,0.24519,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.0226e-05,0.23874,0.37142,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0019282,0.23846,0.17155,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.1493e-05,0.2382,0.23943,1,1
1,GO NUCLEAR EXPORT,5.2837e-06,0.23723,0.21272,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.014841,0.2372,0.18671,1,1
1,GO DNA LIGATION,0.00055855,0.23713,0.27765,1,1
1,GO NEURAL TUBE PATTERNING,0.0083534,0.23708,0.19689,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0027346,0.23693,0.30024,1,1
1,GO HISTONE H2B UBIQUITINATION,0.0023671,0.23682,0.19229,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00040247,0.23659,0.33337,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,3.4421e-05,0.23602,0.21035,1,1
1,GO STRESS FIBER ASSEMBLY,0.0013054,0.23576,0.22434,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0039469,0.23571,0.25188,1,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.026586,0.23566,0.17032,1,1
1,GO MACROPHAGE CHEMOTAXIS,4.3218e-05,0.2356,0.34053,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,0.00092958,0.23532,0.24115,1,1
1,GO RNA METHYLATION,0.00016023,0.23524,0.21371,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0022992,0.23508,0.30992,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00017186,0.23507,0.20824,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.4121e-05,0.23496,0.22285,1,1
1,GO REGULATION OF ANOIKIS,0.040234,0.23482,0.22181,1,1
1,GO MESODERM DEVELOPMENT,5.6174e-05,0.23369,0.20374,1,1
1,GO LIPID STORAGE,0.00095906,0.23358,0.22594,1,1
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00057693,0.23348,0.21432,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00012512,0.23319,0.32709,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.0083534,0.23302,0.26099,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.8418e-05,0.23268,0.34062,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.045624,0.23261,0.23465,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00044439,0.23253,0.29792,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00012512,0.23253,0.19816,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0011549,0.23208,0.26185,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00049035,0.23176,0.34405,1,1
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.035393,0.23171,0.18546,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00013433,0.23166,0.27941,1,1
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0025817,0.23166,0.23483,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0010528,0.23162,0.21027,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00353,0.23159,0.16492,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0045306,0.23159,0.33442,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.00012074,0.23146,0.34564,1,1
1,GO PLATELET ACTIVATION,0.0031536,0.23124,0.19741,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.02843,0.23112,0.23529,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0012662,0.23066,0.24283,1,1
1,GO RNA MODIFICATION,6.2786e-05,0.23061,0.20939,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.0045306,0.23029,0.2233,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,1.2454e-05,0.23022,0.23343,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.029068,0.23012,0.30833,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00034072,0.22989,0.21402,1,1
1,GO PROTEIN TARGETING,0.00019079,0.22982,0.18307,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00010462,0.2298,0.27943,1,1
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.036164,0.22971,0.20874,1,1
1,GO HYPEROSMOTIC RESPONSE,0.0051916,0.22955,0.22019,1,1
1,GO HISTONE H4 DEACETYLATION,0.0075304,0.22953,0.2196,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00049035,0.22915,0.19069,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.017969,0.22915,0.14794,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0019282,0.22889,0.24853,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,1.1964e-05,0.22789,0.23277,1,1
1,GO REGULATION OF IMMUNE RESPONSE,9.0551e-05,0.22775,0.20159,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,8.4205e-05,0.22728,0.25602,1,1
1,GO PLASMA MEMBRANE FUSION,0.035393,0.22722,0.18881,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00090094,0.22714,0.21093,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,3.1888e-05,0.227,0.23447,1,1
1,GO RNA POLYADENYLATION,0.00019079,0.22693,0.18531,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0013054,0.22681,0.24666,1,1
1,GO TRNA MODIFICATION,0.00050664,0.22664,0.20304,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0064317,0.22658,0.18487,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00014418,0.22657,0.21789,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.0054795,0.22625,0.19168,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00092958,0.22612,0.17994,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0067808,0.22579,0.20147,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,8.1192e-05,0.2257,0.26946,1,1
1,GO NEURAL CREST CELL MIGRATION,0.015574,0.22561,0.20388,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.0024367,0.2251,0.22696,1,1
1,GO CERAMIDE TRANSPORT,0.045624,0.2242,0.18002,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.0073e-05,0.22419,0.18716,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.010773,0.22419,0.15992,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00092958,0.22411,0.19037,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.001872,0.22409,0.21907,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00012512,0.22367,0.23902,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.03939,0.22358,0.14755,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00031859,0.22353,0.19543,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.0010859,0.22329,0.25138,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.01282,0.22307,0.21185,1,1
1,GO OVULATION,0.013798,0.22263,0.24588,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00037661,0.22229,0.20994,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00019753,0.22209,0.20984,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.0012662,0.22208,0.1905,1,1
1,GO BONE MORPHOGENESIS,0.0040578,0.22204,0.21741,1,1
1,GO PROTEIN KINASE B SIGNALING,0.00084609,0.22199,0.17657,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0097392,0.22193,0.17672,1,1
1,GO RESPONSE TO BACTERIUM,0.00012964,0.22176,0.23947,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0069616,0.2217,0.1855,1,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.010506,0.22156,0.20365,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00021909,0.22142,0.18319,1,1
1,GO REGULATION OF BONE DEVELOPMENT,0.00072223,0.22109,0.25637,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00017796,0.22106,0.17536,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0022992,0.22105,0.2769,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0057817,0.22086,0.16308,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,0.00013917,0.22078,0.17533,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,2.6307e-05,0.22058,0.2073,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.0099891,0.22053,0.12692,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.018836,0.22026,0.21425,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00353,0.22019,0.1918,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0010859,0.21978,0.20809,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,5.4121e-05,0.21976,0.22902,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0014738,0.21975,0.22396,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.015203,0.21963,0.18459,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0010206,0.21961,0.21601,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0059384,0.21936,0.19338,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.03245,0.21918,0.21293,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0030654,0.21901,0.22776,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00090094,0.21901,0.31678,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0012662,0.21889,0.16917,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.023205,0.21887,0.12887,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.024846,0.21884,0.13098,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.017549,0.2188,0.18144,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.0053338,0.21859,0.20762,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,6.8936e-07,0.21854,0.17236,1,1
1,GO SUPEROXIDE ANION GENERATION,0.0049174,0.21841,0.254,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00069957,0.21821,0.24446,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00012074,0.2182,0.22626,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0064317,0.21766,0.20158,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.00054072,0.21761,0.33478,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.0031536,0.21681,0.23383,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.023741,0.2165,0.15725,1,1
1,GO REGULATION OF URINE VOLUME,0.00074557,0.21647,0.22644,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.4044e-06,0.21628,0.20673,1,1
1,GO TISSUE MIGRATION,0.00032948,0.21609,0.27092,1,1
1,GO RESPONSE TO RETINOIC ACID,0.00095906,0.21608,0.20591,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.001662,0.21592,0.20499,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00024286,0.21534,0.2469,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0017123,0.21518,0.18881,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00024286,0.21501,0.24844,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0015189,0.21418,0.18692,1,1
1,GO GRANULOCYTE MIGRATION,0.00092958,0.21414,0.25515,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0010528,0.21411,0.30391,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0011549,0.214,0.2095,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.00041602,0.2139,0.23627,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00032948,0.21389,0.24244,1,1
1,GO RNA PROCESSING,6.7596e-05,0.21369,0.18101,1,1
1,GO MRNA TRANSPORT,7.2754e-05,0.21354,0.19429,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00098941,0.2132,0.29917,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00017186,0.21296,0.25407,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00017796,0.21269,0.22819,1,1
1,GO MITOPHAGY,0.00069957,0.21231,0.21924,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00063551,0.21196,0.18897,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00031859,0.21189,0.23558,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0094949,0.21181,0.16669,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0022332,0.21173,0.29168,1,1
1,GO DNA DEALKYLATION,0.0051916,0.21169,0.19897,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0013457,0.21138,0.18677,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,3.3287e-06,0.21113,0.24113,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0015189,0.21078,0.20876,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0028141,0.21055,0.22738,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0039469,0.21033,0.19941,1,1
1,GO RUFFLE ORGANIZATION,0.0013872,0.21008,0.16,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0033369,0.21008,0.19728,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,2.1663e-05,0.20992,0.18003,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,4.8612e-06,0.2098,0.22414,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0036303,0.2091,0.1752,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0079323,0.20909,0.23674,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0011199,0.20909,0.27014,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0014299,0.20902,0.17006,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0027346,0.20875,0.26504,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.00018427,0.20873,0.25334,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.027803,0.20859,0.16807,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,6.5896e-07,0.20857,0.18134,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0071468,0.20852,0.17955,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,8.3127e-06,0.20805,0.20832,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0090226,0.20792,0.18039,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00034072,0.20752,0.20366,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0021689,0.20734,0.15502,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.001986,0.2069,0.23508,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,5.2139e-05,0.20666,0.21261,1,1
1,GO OSTEOCLAST DIFFERENTIATION,0.0011199,0.20659,0.17185,1,1
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00035231,0.20658,0.20537,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.001872,0.20655,0.25455,1,1
1,GO PROTEIN DENEDDYLATION,0.014486,0.20629,0.15322,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00087311,0.20599,0.17765,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0031536,0.2057,0.18767,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.024288,0.20552,0.19736,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,8.4205e-05,0.20545,0.19701,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0028141,0.20537,0.19429,1,1
1,GO RNA LOCALIZATION,7.2754e-05,0.20488,0.21001,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00025131,0.2047,0.17973,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,4.0073e-05,0.2041,0.18335,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.024288,0.20391,0.22484,1,1
1,GO TRNA TRANSPORT,0.0045306,0.20381,0.18372,1,1
1,GO DEFENSE RESPONSE,0.00029782,0.20369,0.20284,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0006154,0.20359,0.17767,1,1
1,GO RESPONSE TO GAMMA RADIATION,8.1192e-05,0.20319,0.22332,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.010245,0.20255,0.14809,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0025083,0.20253,0.17454,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00037661,0.20245,0.20501,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,5.4121e-05,0.20228,0.20566,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00090094,0.20228,0.15846,1,1
1,GO PROTEIN AUTOPROCESSING,0.02268,0.20206,0.13976,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.007729,0.20192,0.26843,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0054795,0.20191,0.20765,1,1
1,GO P38MAPK CASCADE,0.0006154,0.20138,0.29126,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0006154,0.20136,0.18714,1,1
1,GO REGULATION OF LIPID STORAGE,0.0014299,0.20122,0.23338,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.022165,0.20082,0.15831,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0041716,0.20072,0.21972,1,1
1,GO REGULATION OF PROTEOLYSIS,0.00021909,0.20056,0.17711,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00057693,0.20037,0.21093,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.4712e-06,0.20027,0.18063,1,1
1,GO MYELOID CELL HOMEOSTASIS,0.00026003,0.20017,0.19025,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.02166,0.19996,0.18332,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0025817,0.19982,0.13712,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0032441,0.19964,0.21694,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,9.0551e-05,0.19935,0.21148,1,1
1,GO MITOTIC CYTOKINESIS,0.0053338,0.19897,0.18318,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00092958,0.19888,0.14788,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.001986,0.19886,0.15915,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0011199,0.19867,0.21459,1,1
1,GO PROTEIN IMPORT,2.7343e-05,0.19864,0.1795,1,1
1,GO MIDBODY ABSCISSION,0.014841,0.19861,0.19748,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.037747,0.19853,0.17831,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.046579,0.19844,0.17788,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,0.00025131,0.19841,0.25338,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0045306,0.1983,0.22474,1,1
1,GO REGULATION OF DEFENSE RESPONSE,0.00038934,0.19803,0.18438,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00035231,0.19796,0.17181,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.011326,0.19748,0.20946,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.010773,0.19713,0.237,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0010528,0.19671,0.16329,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00084609,0.19664,0.21238,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00074557,0.19663,0.16279,1,1
1,GO LACTATION,0.0040578,0.1965,0.18875,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.024846,0.19637,0.20977,1,1
1,GO RESPONSE TO KETONE,0.018836,0.19627,0.11658,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0071468,0.19587,0.1784,1,1
1,GO VESICLE TARGETING,0.0001165,0.19585,0.21485,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.017969,0.19585,0.15723,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00079435,0.1955,0.18646,1,1
1,GO REGULATION OF HEMOPOIESIS,0.00030804,0.19516,0.17792,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00030804,0.19504,0.15829,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.011904,0.19483,0.17087,1,1
1,GO CELL AGING,6.2367e-06,0.19481,0.21167,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00022676,0.19439,0.19163,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.036948,0.19421,0.20007,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.046579,0.19349,0.1547,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.020205,0.19345,0.15477,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00027832,0.19332,0.21489,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0021689,0.19315,0.19035,1,1
1,GO MEMBRANE BIOGENESIS,0.045624,0.19312,0.17318,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.0784e-06,0.19244,0.1902,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.017549,0.19226,0.16314,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.042857,0.19202,0.27372,1,1
1,GO PEPTIDYL METHIONINE MODIFICATION,0.0017641,0.192,0.22153,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0054795,0.19191,0.17825,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0019282,0.19171,0.14475,1,1
1,GO PROTEIN PROCESSING,0.0014738,0.19168,0.1828,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0069616,0.19166,0.33281,1,1
1,GO LYMPHOCYTE ACTIVATION,0.00038934,0.19155,0.17726,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.017137,0.19113,0.13983,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,4.6597e-05,0.19112,0.18612,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0020453,0.1911,0.18306,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00030804,0.19102,0.18342,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.017549,0.19097,0.17537,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00072223,0.19066,0.16292,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00079435,0.1906,0.18922,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.0053338,0.19035,0.16466,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00041602,0.19033,0.21259,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00079435,0.1903,0.17552,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00018427,0.19027,0.1781,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.7474e-06,0.18985,0.18482,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,1.9263e-05,0.18978,0.18244,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0006154,0.18977,0.18817,1,1
1,GO T CELL ACTIVATION,0.00054072,0.18962,0.1888,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,0.00023468,0.18952,0.17337,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.019739,0.18892,0.17892,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00041602,0.18878,0.17133,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.0021062,0.18877,0.17846,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.0007696,0.18864,0.14804,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.02166,0.18844,0.16664,1,1
1,GO NUCLEAR TRANSPORT,2.4346e-05,0.18833,0.16069,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,8.1192e-05,0.1883,0.20516,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00038934,0.18798,0.18693,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.0073363,0.18797,0.17609,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,0.00052342,0.18772,0.20986,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.001228,0.18757,0.18921,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00028792,0.1872,0.18878,1,1
1,GO CELL ACTIVATION,0.00021167,0.18702,0.20764,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.0099891,0.18693,0.17558,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0041716,0.1863,0.19194,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.0062634,0.18627,0.24566,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.7118e-05,0.18588,0.21535,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.014486,0.18581,0.18023,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,8.3127e-06,0.18498,0.15435,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,0.00025131,0.18497,0.16707,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,3.3132e-05,0.18486,0.17539,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.010245,0.18485,0.15242,1,1
1,GO GRANULOCYTE CHEMOTAXIS,0.013139,0.18482,0.224,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,5.4121e-05,0.18479,0.2081,1,1
1,GO ORGANELLE INHERITANCE,0.0042883,0.18403,0.15861,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.001228,0.1838,0.14694,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.010506,0.18374,0.13998,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,1.0184e-05,0.18342,0.15803,1,1
1,GO INFLAMMATORY RESPONSE,0.0006154,0.18333,0.22019,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0075304,0.18332,0.18162,1,1
1,GO MESENCHYME DEVELOPMENT,0.0032441,0.18252,0.184,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.038561,0.1824,0.20183,1,1
1,GO PROTEIN NEDDYLATION,0.0010859,0.18232,0.19318,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0057817,0.18192,0.2017,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,4.0073e-05,0.18187,0.21687,1,1
1,GO CENTRIOLE ASSEMBLY,0.011047,0.18179,0.12131,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.0042883,0.18173,0.15529,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0013457,0.18141,0.15839,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00041602,0.18081,0.14731,1,1
1,GO TUBE MORPHOGENESIS,0.0010859,0.18081,0.18803,1,1
1,GO PEPTIDYL ARGININE METHYLATION,0.014138,0.18038,0.15302,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0030654,0.18028,0.17507,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,3.5759e-05,0.18001,0.20774,1,1
1,GO PROTEIN MATURATION,0.00063551,0.17999,0.14183,1,1
1,GO RNA CAPPING,3.5759e-05,0.17984,0.18093,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00079435,0.17948,0.14263,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.024846,0.17885,0.14483,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.029719,0.1785,0.23717,1,1
1,GO FACE DEVELOPMENT,0.001986,0.17832,0.22907,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0090226,0.17826,0.27813,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.026586,0.17788,0.19912,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.033166,0.17747,0.16379,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00023468,0.17718,0.23974,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00029782,0.17714,0.15258,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0037331,0.17713,0.15819,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.001662,0.1764,0.12933,1,1
1,GO RESPONSE TO STEROID HORMONE,0.0042883,0.17635,0.14852,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00054072,0.1761,0.18674,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.0022992,0.17593,0.22905,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.0013872,0.17533,0.15618,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.011326,0.17492,0.18565,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0057817,0.17469,0.14603,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,4.1617e-05,0.17459,0.2088,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00044439,0.17438,0.1359,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0028957,0.17427,0.20299,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0014299,0.17413,0.16731,1,1
1,GO GOLGI VESICLE TRANSPORT,5.8301e-05,0.17379,0.16059,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00017796,0.17348,0.17718,1,1
1,GO CELLULAR RESPONSE TO LIPID,0.00074557,0.17329,0.17577,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00026003,0.17309,0.18584,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0073363,0.17298,0.15541,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0059384,0.1728,0.20046,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00026003,0.1725,0.22913,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.02068,0.17239,0.15365,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0014738,0.17235,0.20033,1,1
1,GO AGING,0.00042998,0.17234,0.16316,1,1
1,GO RESPONSE TO ISCHEMIA,0.00042998,0.17219,0.1899,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0011549,0.17202,0.24006,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0025083,0.17148,0.1669,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.011904,0.17146,0.16461,1,1
1,GO LYSOSOMAL TRANSPORT,0.0012662,0.17139,0.1612,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0067808,0.17128,0.24452,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0014299,0.17106,0.21399,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.012203,0.17095,0.13097,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0046564,0.1707,0.13167,1,1
1,GO MITOTIC RECOMBINATION,0.0051916,0.1707,0.18694,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,0.00028792,0.17062,0.14817,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0022332,0.17034,0.12988,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00095906,0.17034,0.20275,1,1
1,GO RESPONSE TO CHEMOKINE,0.015953,0.17034,0.19109,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0017641,0.17018,0.14627,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.00045924,0.17003,0.20714,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0039469,0.16991,0.18678,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.001228,0.16983,0.15022,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,5.8301e-05,0.16941,0.16845,1,1
1,GO POSITIVE CHEMOTAXIS,0.015953,0.16938,0.2003,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0054795,0.16934,0.16584,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0051916,0.16905,0.1431,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0038387,0.16872,0.15354,1,1
1,GO PEROXISOME ORGANIZATION,0.0026572,0.16869,0.17555,1,1
1,GO MRNA METABOLIC PROCESS,2.7343e-05,0.16862,0.16685,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.00029782,0.16856,0.17001,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0016129,0.16852,0.17406,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,0.0019282,0.16847,0.17446,1,1
1,GO BLASTOCYST GROWTH,0.0059384,0.16823,0.22956,1,1
1,GO VACUOLAR TRANSPORT,0.0017641,0.1682,0.13853,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.02068,0.16812,0.21955,1,1
1,GO IMPORT INTO NUCLEUS,0.00023468,0.16798,0.14576,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.010506,0.16796,0.19485,1,1
1,GO DRUG METABOLIC PROCESS,0.038561,0.16779,0.10459,1,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.025994,0.16757,0.11483,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.0038387,0.16738,0.11314,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0013872,0.16729,0.16396,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0042883,0.16668,0.1798,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0047853,0.16654,0.17888,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0083534,0.1665,0.12902,1,1
1,GO NEUTROPHIL MIGRATION,0.020205,0.16634,0.20788,1,1
1,GO PROTEIN KINASE A SIGNALING,5.6174e-05,0.16629,0.22147,1,1
1,GO REGULATION OF RESPONSE TO STRESS,0.00026903,0.16626,0.14566,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00059588,0.16596,0.17619,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00065623,0.16581,0.15737,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0024367,0.16567,0.18407,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.020205,0.16565,0.15313,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,2.8418e-05,0.16465,0.16689,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.0041716,0.16417,0.1508,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.013798,0.16405,0.14177,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.036948,0.16399,0.10833,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,1.104e-05,0.16397,0.15136,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0010206,0.16374,0.17992,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00017796,0.16367,0.14066,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,2.3418e-05,0.16349,0.22609,1,1
1,GO RESPONSE TO PH,0.045624,0.16319,0.17331,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0059384,0.16317,0.15232,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.001986,0.16294,0.17695,1,1
1,GO OSSIFICATION,0.0066042,0.16293,0.16221,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00029782,0.16287,0.15463,1,1
1,GO TRANSLESION SYNTHESIS,0.00353,0.16219,0.14547,1,1
1,GO TELOMERE ORGANIZATION,0.00050664,0.16219,0.13693,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0066042,0.1621,0.14485,1,1
1,GO VACUOLE ORGANIZATION,0.00065623,0.16206,0.13687,1,1
1,GO SPINDLE LOCALIZATION,0.001986,0.16145,0.14183,1,1
1,GO PROTEIN POLYUBIQUITINATION,4.4878e-05,0.161,0.15096,1,1
1,GO GLOMERULUS DEVELOPMENT,0.0012662,0.16071,0.32915,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.0097392,0.16069,0.15819,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.024846,0.16063,0.083591,1,1
1,GO MYELOID CELL DIFFERENTIATION,0.00042998,0.16029,0.15349,1,1
1,GO CELL KILLING,0.02166,0.15996,0.12643,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.001872,0.15896,0.15488,1,1
1,GO ACUTE PHASE RESPONSE,0.02268,0.15896,0.22461,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0025817,0.15896,0.15038,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00098941,0.15832,0.26283,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,5.2837e-06,0.15801,0.1627,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0053338,0.15744,0.20701,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.023741,0.1573,0.11337,1,1
1,GO PROTEOLYSIS,0.0001547,0.15686,0.13128,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0011549,0.1568,0.14059,1,1
1,GO ERBB SIGNALING PATHWAY,0.001872,0.15667,0.20485,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.0062634,0.1565,0.12681,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0075304,0.15616,0.15126,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,1.7806e-05,0.15603,0.14411,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0021062,0.15593,0.16158,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,2.5308e-05,0.15588,0.15012,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0075304,0.15523,0.17054,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.0024367,0.15513,0.20935,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00049035,0.15438,0.1412,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00010462,0.15415,0.15423,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.0079323,0.15411,0.18356,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,3.1888e-05,0.154,0.15978,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.026586,0.15373,0.14494,1,1
1,GO REGULATION OF BONE MINERALIZATION,0.024846,0.15364,0.18196,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00010845,0.15364,0.15037,1,1
1,GO MAINTENANCE OF LOCATION,0.00016023,0.1534,0.15799,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0025083,0.15331,0.20168,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,7.547e-05,0.15305,0.16852,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.016734,0.1527,0.22123,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0090226,0.15257,0.15517,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0083534,0.15246,0.18106,1,1
1,GO BONE DEVELOPMENT,0.0027346,0.15235,0.18057,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0040578,0.15233,0.15526,1,1
1,GO PROTEIN CATABOLIC PROCESS,2.5308e-05,0.15231,0.13921,1,1
1,GO REGULATION OF BODY FLUID LEVELS,0.0039469,0.15227,0.15763,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0014299,0.15189,0.14605,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,1.9263e-05,0.15177,0.14455,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.045624,0.15162,0.10203,1,1
1,GO B CELL ACTIVATION,0.0023671,0.15151,0.1324,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.035393,0.15142,0.15752,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00042998,0.15101,0.14354,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.7596e-05,0.15091,0.14901,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.025994,0.15085,0.16322,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.0041716,0.15055,0.10854,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0013054,0.15024,0.16585,1,1
1,GO REGULATION OF MYELINATION,0.035393,0.15014,0.11144,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0013457,0.14979,0.14527,1,1
1,GO PROTEIN STABILIZATION,0.00081984,0.14976,0.13557,1,1
1,GO REGULATION OF BINDING,0.0034322,0.14932,0.12023,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,1.2962e-05,0.14888,0.16102,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.0050528,0.14871,0.13643,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00047456,0.14801,0.14455,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,0.00081984,0.14795,0.13331,1,1
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.045624,0.14778,0.13469,1,1
1,GO RESPONSE TO UV,0.00090094,0.14777,0.14137,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00038934,0.14743,0.11963,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00037661,0.14727,0.16203,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0087944,0.14723,0.10471,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0051916,0.14709,0.14359,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.013139,0.14682,0.15376,1,1
1,GO REGULATION OF PROTEIN BINDING,0.0010206,0.14649,0.14394,1,1
1,GO HEART VALVE DEVELOPMENT,0.0041716,0.14631,0.22713,1,1
1,GO REGULATION OF CATABOLIC PROCESS,9.0179e-06,0.14626,0.14604,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00095906,0.14624,0.19238,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.001986,0.14606,0.21022,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0011549,0.14597,0.12961,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0064317,0.14597,0.18494,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.00026903,0.1453,0.14797,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0075304,0.14529,0.24712,1,1
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0045306,0.14513,0.15444,1,1
1,GO NEURAL TUBE FORMATION,0.017969,0.14497,0.15986,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00034072,0.14495,0.13894,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.013465,0.14478,0.13873,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.011612,0.14472,0.14563,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0045306,0.14471,0.1453,1,1
1,GO BODY FLUID SECRETION,0.00047456,0.14469,0.19926,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.001228,0.14467,0.13817,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0079323,0.14467,0.14972,1,1
1,GO NCRNA CATABOLIC PROCESS,0.040234,0.14454,0.14855,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.023741,0.14453,0.15399,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0013054,0.14452,0.11892,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.01282,0.14421,0.13661,1,1
1,GO VACUOLAR ACIDIFICATION,0.011047,0.14387,0.14856,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.0010206,0.14326,0.14643,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.02166,0.14317,0.16843,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00016595,0.14296,0.16526,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.012203,0.14268,0.13628,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0022992,0.14251,0.10593,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.027188,0.14225,0.11214,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00026003,0.1422,0.18714,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00052342,0.14207,0.15198,1,1
1,GO HISTONE DEACETYLATION,0.0019282,0.14151,0.11478,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.015203,0.1411,0.1172,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0023671,0.14083,0.16764,1,1
1,GO GOLGI ORGANIZATION,0.0022332,0.14082,0.12195,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.0021689,0.14047,0.11036,1,1
1,GO TRABECULA MORPHOGENESIS,0.0097392,0.14038,0.20547,1,1
1,GO GENE SILENCING,6.0504e-05,0.14012,0.13898,1,1
1,GO CELLULAR RESPONSE TO UV,0.0059384,0.13961,0.13052,1,1
1,GO DNA BIOSYNTHETIC PROCESS,2.5774e-06,0.13951,0.16256,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00098941,0.1394,0.15761,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0031536,0.13903,0.12868,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.025994,0.13883,0.13241,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00049035,0.1387,0.12962,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,3.8583e-05,0.13859,0.17871,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00010845,0.13742,0.13557,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00045924,0.13732,0.11525,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0017641,0.13719,0.17394,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.0085714,0.13709,0.11019,1,1
1,GO POSTREPLICATION REPAIR,0.0022992,0.1364,0.13019,1,1
1,GO NUCLEUS ORGANIZATION,0.0042883,0.13624,0.11853,1,1
1,GO ENDOSOME ORGANIZATION,0.0059384,0.13593,0.13598,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00023468,0.135,0.1355,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0049174,0.13485,0.090557,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.023741,0.13471,0.19406,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0010206,0.13425,0.13726,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0060989,0.13415,0.19709,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,7.8282e-05,0.13409,0.12266,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.011612,0.13398,0.13323,1,1
1,GO REGULATION OF MAPK CASCADE,0.0039469,0.13398,0.12762,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.0066042,0.13381,0.11213,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.026586,0.13343,0.12477,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0060989,0.13331,0.16941,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.013139,0.13301,0.15874,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.0024367,0.1328,0.1425,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0029794,0.13261,0.14324,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.015574,0.13249,0.1001,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.0051916,0.13215,0.14529,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.036164,0.13209,0.094694,1,1
1,GO VIRAL BUDDING,0.0097392,0.13148,0.13175,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,9.0551e-05,0.13088,0.1419,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00021167,0.13081,0.15226,1,1
1,GO GENITALIA DEVELOPMENT,0.024288,0.13028,0.09985,1,1
1,GO STEM CELL DIFFERENTIATION,0.00079435,0.13003,0.15378,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00047456,0.13002,0.13104,1,1
1,GO MRNA 3 END PROCESSING,0.0034322,0.12957,0.13049,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.026586,0.1295,0.14574,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.014841,0.12947,0.08906,1,1
1,GO MIRNA METABOLIC PROCESS,0.0049174,0.12895,0.15298,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.0059384,0.12849,0.098361,1,1
1,GO REGULATION OF LIPID TRANSPORT,0.0037331,0.12823,0.13032,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0013872,0.12764,0.16598,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0023671,0.12744,0.14008,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0051916,0.12743,0.12081,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.011326,0.1269,0.13384,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.001662,0.1269,0.14045,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0056288,0.12678,0.13169,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0081404,0.12677,0.18129,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0038387,0.12635,0.12253,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0021062,0.12631,0.13619,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.046579,0.12612,0.092054,1,1
1,GO BASE EXCISION REPAIR,0.010245,0.1256,0.13917,1,1
1,GO MRNA CLEAVAGE,0.00024286,0.12559,0.14981,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,3.1888e-05,0.12549,0.13787,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.00031859,0.12504,0.13384,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.017549,0.12488,0.12256,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.017969,0.12456,0.096426,1,1
1,GO RNA SURVEILLANCE,0.0011199,0.12395,0.20008,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,2.0033e-05,0.12358,0.11727,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011047,0.12333,0.15834,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.016734,0.12289,0.079261,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.024288,0.12251,0.11726,1,1
1,GO ORGAN GROWTH,0.0057817,0.12249,0.16116,1,1
1,GO REGULATION OF DNA REPAIR,0.004408,0.12235,0.10094,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0026572,0.12216,0.11226,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00023468,0.12208,0.10822,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0021689,0.12201,0.11178,1,1
1,GO TUBE DEVELOPMENT,0.0081404,0.12178,0.14091,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0057817,0.12148,0.10437,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,8.1192e-05,0.12139,0.13679,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.010506,0.12118,0.098401,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0013872,0.12103,0.1676,1,1
1,GO RESPONSE TO LIPID,0.0050528,0.12099,0.13855,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0051916,0.12022,0.11553,1,1
1,GO LEUKOCYTE DIFFERENTIATION,0.0027346,0.11993,0.13946,1,1
1,GO CELLULAR SENESCENCE,0.0014738,0.11989,0.13232,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.03939,0.11915,0.078736,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.036164,0.11874,0.098434,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0040578,0.11847,0.13759,1,1
1,GO REGULATION OF OSSIFICATION,0.020205,0.11837,0.15274,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.0031536,0.11808,0.11777,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.007729,0.11757,0.089514,1,1
1,GO REGULATION OF CELL DEATH,0.0022992,0.11732,0.11088,1,1
1,GO APOPTOTIC PROCESS,0.0014299,0.11701,0.10691,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.043763,0.11686,0.1667,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0087944,0.11682,0.11365,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.001872,0.11625,0.1189,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,2.3418e-05,0.11605,0.14955,1,1
1,GO CELL DIVISION,0.020205,0.11603,0.087722,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.020205,0.11599,0.092396,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.024288,0.11537,0.16301,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0081404,0.1146,0.11075,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.015953,0.11422,0.085296,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00057693,0.11359,0.10571,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0062634,0.11331,0.10324,1,1
1,GO MEMBRANE ORGANIZATION,0.0094949,0.11274,0.08457,1,1
1,GO ORGANELLE FISSION,0.040234,0.11178,0.073333,1,1
1,GO FEMALE GAMETE GENERATION,0.011904,0.11153,0.082668,1,1
1,GO RESPONSE TO PEPTIDE,0.0099891,0.11137,0.083111,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.016339,0.11119,0.15225,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0060989,0.11079,0.10978,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0067808,0.10955,0.094662,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.029719,0.10947,0.10963,1,1
1,GO OVULATION CYCLE,0.042857,0.10943,0.13541,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.025994,0.10911,0.10638,1,1
1,GO ORGANELLE DISASSEMBLY,0.00092958,0.10897,0.11451,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0040578,0.1087,0.153,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0025817,0.10861,0.1111,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.013139,0.10854,0.11638,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.010773,0.10851,0.11115,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.045624,0.10823,0.11898,1,1
1,GO MACROAUTOPHAGY,0.00010092,0.10746,0.13027,1,1
1,GO MESENCHYME MORPHOGENESIS,0.027188,0.10713,0.24643,1,1
1,GO REGULATION OF AUTOPHAGY,0.0020453,0.10667,0.10507,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0050528,0.10665,0.099759,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.010773,0.10651,0.085831,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0051916,0.10564,0.18674,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0019282,0.10561,0.10139,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00026903,0.10532,0.095544,1,1
1,GO SULFATE TRANSPORT,0.004408,0.10504,0.12295,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0025083,0.10431,0.17797,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.0085714,0.10415,0.17113,1,1
1,GO PERICARDIUM DEVELOPMENT,0.02268,0.10399,0.1797,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0012662,0.10382,0.07631,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.03939,0.10354,0.09134,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.012508,0.10254,0.11037,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.001662,0.10211,0.083986,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.014841,0.10178,0.074554,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.013798,0.10134,0.12615,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.025414,0.10107,0.091629,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.0015189,0.10052,0.13129,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.011612,0.10014,0.13401,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.015203,0.1001,0.12259,1,1
1,GO FLUID TRANSPORT,0.018836,0.099557,0.10802,1,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.02068,0.09938,0.20659,1,1
1,GO MITOTIC CELL CYCLE,0.015203,0.097865,0.089583,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.040234,0.097845,0.10694,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00026003,0.096419,0.10892,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0060989,0.096167,0.10212,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.012508,0.096005,0.089579,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.027803,0.095777,0.069638,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.024288,0.095725,0.086623,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.017137,0.094908,0.094604,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0069616,0.094234,0.084378,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014841,0.094044,0.11393,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0047853,0.094025,0.09543,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.015953,0.093748,0.10165,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.011612,0.092602,0.084102,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00092958,0.092091,0.14287,1,1
1,GO CELL CYCLE PROCESS,0.025414,0.091379,0.071956,1,1
1,GO RESPONSE TO HORMONE,0.016339,0.091093,0.086917,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.025994,0.0906,0.087667,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00016595,0.090572,0.10882,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.02843,0.09053,0.10956,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.015574,0.090221,0.0992,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.0051916,0.089732,0.091377,1,1
1,GO ENDOCYTOSIS,0.0047853,0.088995,0.11,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00019753,0.08863,0.10053,1,1
1,GO RUFFLE ASSEMBLY,0.036948,0.088542,0.10331,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.015953,0.08844,0.10387,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.010506,0.088328,0.12564,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00059588,0.087704,0.08957,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0053338,0.08754,0.072947,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.020205,0.08723,0.082638,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.017969,0.085997,0.077041,1,1
1,GO DNA METABOLIC PROCESS,0.00081984,0.085621,0.091373,1,1
1,GO SNRNA TRANSCRIPTION,0.0041716,0.085252,0.10106,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00030804,0.085186,0.092035,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.030383,0.084262,0.093936,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.019283,0.083716,0.075343,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.016339,0.083705,0.055371,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.016339,0.083256,0.067145,1,1
1,GO CHROMOSOME CONDENSATION,0.0085714,0.080985,0.12162,1,1
1,GO HEART DEVELOPMENT,0.022165,0.080762,0.11261,1,1
1,GO MULTI ORGANISM PROCESS,0.021165,0.080325,0.045216,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.031059,0.076283,0.06717,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.019739,0.075168,0.11763,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.009256,0.074853,0.093269,1,1
1,GO INTRACELLULAR TRANSPORT,0.0038387,0.07238,0.070024,1,1
1,GO CELL CYCLE,0.036164,0.071665,0.05901,1,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.029068,0.071049,0.054202,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0079323,0.070095,0.085424,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.029068,0.06974,0.068459,1,1
1,GO CHROMOSOME SEPARATION,0.026586,0.067543,0.12303,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.031059,0.064163,0.08662,1,1
1,GO REGULATION OF DNA REPLICATION,0.03939,0.061645,0.077517,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.015953,0.061405,0.11483,1,1
1,GO DNA RECOMBINATION,0.029068,0.059759,0.088278,1,1
1,GO DNA REPAIR,0.010245,0.057119,0.076951,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.007729,0.054613,0.058025,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.018398,0.052138,0.072076,1,1
1,GO ORGANELLE ASSEMBLY,0.041967,0.043742,0.049123,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0028141,0.85777,0.61039,1,1
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00055855,0.77052,0.73588,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0015189,0.72448,0.65131,1,1
2,GO SYNAPSE MATURATION,0.011326,0.66398,0.47096,1,1
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0094949,0.63675,0.4498,1,1
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00031859,0.60751,0.48866,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0036303,0.58484,0.45279,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00012074,0.57306,0.62116,1,1
2,GO DENSE CORE GRANULE TRANSPORT,0.001228,0.56705,0.50057,1,1
2,GO POSTSYNAPSE ASSEMBLY,0.0031536,0.55968,0.45714,1,1
2,GO CARDIAC VENTRICLE FORMATION,0.00037661,0.54808,0.58961,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0026572,0.53851,0.44522,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0024367,0.52954,0.45325,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.010773,0.5186,0.35968,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,0.0001165,0.50135,0.41028,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0062634,0.49616,0.33205,1,1
2,GO NEURON CELLULAR HOMEOSTASIS,0.00021909,0.48786,0.38323,1,1
2,GO SECRETORY GRANULE LOCALIZATION,0.00045924,0.48471,0.44533,1,1
2,GO PLASMA MEMBRANE REPAIR,0.012203,0.48326,0.33366,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,5.0226e-05,0.46631,0.43798,1,1
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0094949,0.46573,0.42297,1,1
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00014935,0.45371,0.48737,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0060989,0.45026,0.31972,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00353,0.44524,0.33401,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.00026003,0.44324,0.36582,1,1
2,GO PYRAMIDAL NEURON DIFFERENTIATION,0.0010859,0.42907,0.44681,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0032441,0.42023,0.3143,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,0.0083534,0.41795,0.3105,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00067758,0.41401,0.37598,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.038561,0.40252,0.22758,1,1
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0025083,0.39694,0.33837,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00010845,0.38845,0.41162,1,1
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.014486,0.3884,0.30136,1,1
2,GO TELENCEPHALON REGIONALIZATION,0.0090226,0.38838,0.30548,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0020453,0.3833,0.32655,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.019739,0.37803,0.35725,1,1
2,GO SUCKLING BEHAVIOR,1.9263e-05,0.37762,0.41522,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.02068,0.3748,0.257,1,1
2,GO PREPULSE INHIBITION,0.043763,0.37414,0.26678,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0079323,0.37194,0.29316,1,1
2,GO PROTEIN LOCALIZATION TO AXON,0.019739,0.36807,0.39298,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0051916,0.36679,0.33878,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00029782,0.36474,0.41958,1,1
2,GO VOCALIZATION BEHAVIOR,0.0073363,0.36361,0.42002,1,1
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0075304,0.36221,0.31731,1,1
2,GO REGULATION OF VESICLE FUSION,0.029719,0.36124,0.1878,1,1
2,GO REGULATION OF NEURON MIGRATION,0.00036427,0.36077,0.29103,1,1
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.015953,0.35934,0.24381,1,1
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.0090226,0.35887,0.31598,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00016595,0.35784,0.41239,1,1
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0097392,0.35741,0.29928,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,2.6307e-05,0.35732,0.37506,1,1
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.024288,0.35275,0.32134,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,5.0226e-05,0.35165,0.31094,1,1
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0047853,0.35053,0.31086,1,1
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.004408,0.34638,0.25552,1,1
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0060989,0.34054,0.27862,1,1
2,GO ADULT FEEDING BEHAVIOR,0.00052342,0.3397,0.27914,1,1
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.010245,0.33152,0.27901,1,1
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0040578,0.33143,0.23422,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0051916,0.32914,0.31937,1,1
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.00098941,0.32747,0.33641,1,1
2,GO CHEMOSENSORY BEHAVIOR,0.00026003,0.326,0.2852,1,1
2,GO ANATOMICAL STRUCTURE REGRESSION,0.030383,0.32578,0.25229,1,1
2,GO DENDRITIC SPINE MORPHOGENESIS,0.0051916,0.32196,0.26949,1,1
2,GO NEGATIVE CHEMOTAXIS,0.0054795,0.31776,0.23499,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.015953,0.31735,0.22737,1,1
2,GO CGMP METABOLIC PROCESS,0.015203,0.31671,0.29677,1,1
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0033369,0.31578,0.26154,1,1
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.0059384,0.31381,0.27242,1,1
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0039469,0.31175,0.27715,1,1
2,GO NEURON PROJECTION ORGANIZATION,0.0069616,0.31028,0.22293,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0012662,0.30681,0.29212,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0062634,0.30426,0.40329,1,1
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0060989,0.30264,0.30155,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0060989,0.30139,0.26026,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.0045306,0.29916,0.29343,1,1
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00090094,0.29851,0.32004,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0053338,0.2938,0.25831,1,1
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00038934,0.29347,0.23589,1,1
2,GO ADULT HEART DEVELOPMENT,0.00098941,0.29328,0.3642,1,1
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.014486,0.29133,0.31581,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.011326,0.291,0.22855,1,1
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0094949,0.28856,0.19987,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0046564,0.28741,0.27237,1,1
2,GO MESODERMAL CELL FATE SPECIFICATION,0.013139,0.28732,0.21984,1,1
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0022992,0.28216,0.24791,1,1
2,GO UV PROTECTION,0.0026572,0.28123,0.24353,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.013798,0.28111,0.29194,1,1
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010245,0.28028,0.22756,1,1
2,GO DENDRITIC TRANSPORT,3.5759e-05,0.2776,0.34404,1,1
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0049174,0.27099,0.24662,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0022992,0.26619,0.25155,1,1
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.00069957,0.26492,0.27608,1,1
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0066042,0.26483,0.2243,1,1
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0024367,0.26195,0.25355,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00014418,0.26119,0.28029,1,1
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.013139,0.26022,0.26732,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.036948,0.25433,0.2541,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.036164,0.25192,0.14948,1,1
2,GO PEPTIDYL ARGININE N METHYLATION,0.0042883,0.25129,0.19595,1,1
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0097392,0.25121,0.22172,1,1
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0081404,0.25079,0.22414,1,1
2,GO POSTSYNAPSE ORGANIZATION,0.0047853,0.24907,0.20703,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0073363,0.2474,0.21746,1,1
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00019079,0.24345,0.24222,1,1
2,GO MOTOR NEURON AXON GUIDANCE,0.00022676,0.24232,0.24072,1,1
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.0013054,0.24219,0.2315,1,1
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.016339,0.24103,0.19965,1,1
2,GO NEURON MIGRATION,0.001662,0.23822,0.22965,1,1
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.033894,0.23808,0.15751,1,1
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.02843,0.23445,0.17558,1,1
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.0021689,0.23324,0.19955,1,1
2,GO DENDRITIC SPINE DEVELOPMENT,0.017137,0.23193,0.1953,1,1
2,GO NEURON PROJECTION GUIDANCE,0.001228,0.22938,0.20642,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.029719,0.22818,0.15186,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0069616,0.2277,0.27661,1,1
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.02068,0.22557,0.19928,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.001986,0.22508,0.20165,1,1
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.02068,0.22481,0.20845,1,1
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.011904,0.22269,0.18919,1,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.025414,0.21658,0.18726,1,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0062634,0.21597,0.21313,1,1
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.013139,0.21553,0.16064,1,1
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0037331,0.2137,0.25044,1,1
2,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.21311,0.20867,1,1
2,GO PRESYNAPSE ORGANIZATION,0.037747,0.21175,0.16234,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.0047853,0.20945,0.1837,1,1
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0042883,0.20926,0.24029,1,1
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0022992,0.20913,0.22716,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.036948,0.20903,0.15597,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.045624,0.20601,0.17377,1,1
2,GO SYNAPSE ORGANIZATION,0.0097392,0.2042,0.16129,1,1
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0026572,0.20359,0.24347,1,1
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0053338,0.20117,0.34525,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0087944,0.20081,0.17405,1,1
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.0015189,0.1998,0.19184,1,1
2,GO STRESS GRANULE ASSEMBLY,0.010245,0.19895,0.13678,1,1
2,GO AXON EXTENSION,0.0046564,0.19892,0.17781,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.038561,0.19875,0.16923,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.033166,0.1983,0.19885,1,1
2,GO REGULATION OF AXONOGENESIS,0.0064317,0.19608,0.1864,1,1
2,GO REGULATION OF LYASE ACTIVITY,0.031748,0.19482,0.16327,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.009256,0.19288,0.16936,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.001986,0.19057,0.18506,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.01282,0.18773,0.16237,1,1
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0057817,0.18616,0.18082,1,1
2,GO RNA SURVEILLANCE,0.037747,0.18481,0.1306,1,1
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.0081404,0.18202,0.18751,1,1
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0067808,0.18111,0.14867,1,1
2,GO HISTONE ARGININE METHYLATION,0.00069957,0.18025,0.16839,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.016339,0.17908,0.14394,1,1
2,GO ASSOCIATIVE LEARNING,0.0056288,0.17778,0.1718,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.025994,0.17747,0.1444,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0087944,0.17546,0.11984,1,1
2,GO REGULATION OF AXON GUIDANCE,0.0090226,0.17531,0.17269,1,1
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0067808,0.17486,0.22758,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.022165,0.17189,0.18264,1,1
2,GO SYNAPTIC VESICLE LOCALIZATION,0.0038387,0.17151,0.23328,1,1
2,GO TUBULIN DEACETYLATION,0.040234,0.17134,0.17,1,1
2,GO SNORNA METABOLIC PROCESS,0.009256,0.17125,0.19146,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.045624,0.16976,0.19099,1,1
2,GO PROTEIN TRIMERIZATION,0.045624,0.16793,0.18172,1,1
2,GO NEURON PROJECTION EXTENSION,0.0027346,0.16765,0.16986,1,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0022992,0.167,0.17238,1,1
2,GO PEPTIDYL ARGININE METHYLATION,0.0024367,0.16649,0.1377,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0066042,0.16533,0.153,1,1
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.011612,0.16397,0.11962,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.011326,0.16371,0.1419,1,1
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00016023,0.16345,0.18899,1,1
2,GO RESPIRATORY SYSTEM PROCESS,0.031059,0.1625,0.14988,1,1
2,GO NEUROTRANSMITTER SECRETION,0.011904,0.15639,0.22028,1,1
2,GO SYNAPSE ASSEMBLY,0.027188,0.155,0.15438,1,1
2,GO METENCEPHALON DEVELOPMENT,0.011326,0.15458,0.16538,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.014841,0.15402,0.19239,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.015203,0.15065,0.16117,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0053338,0.14703,0.11818,1,1
2,GO PROTEIN O LINKED MANNOSYLATION,0.041967,0.14389,0.099445,1,1
2,GO HIPPOCAMPUS DEVELOPMENT,0.0094949,0.14218,0.1869,1,1
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0066042,0.14163,0.13494,1,1
2,GO NEUROTRANSMITTER TRANSPORT,0.017549,0.14064,0.19322,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.033166,0.13626,0.10181,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.022165,0.13416,0.1837,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.034637,0.13399,0.13545,1,1
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.019283,0.13153,0.11898,1,1
2,GO REGULATION OF NEURON DIFFERENTIATION,0.014486,0.12911,0.11392,1,1
2,GO REPLICATION FORK PROCESSING,0.025414,0.12388,0.11041,1,1
2,GO DNA REPLICATION INITIATION,0.015953,0.12186,0.11614,1,1
2,GO NEURON DIFFERENTIATION,0.015574,0.11662,0.1061,1,1
2,GO TELENCEPHALON DEVELOPMENT,0.0046564,0.1146,0.13304,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.035393,0.11347,0.099916,1,1
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0024367,0.11202,0.13569,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0090226,0.10747,0.13207,1,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.043763,0.10459,0.11592,1,1
2,GO DNA DEPENDENT DNA REPLICATION,0.027803,0.10088,0.077101,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.02843,0.10082,0.074038,1,1
2,GO MRNA METHYLATION,0.019283,0.10065,0.16132,1,1
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.037747,0.098442,0.087846,1,1
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.012508,0.096338,0.096869,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.033166,0.09506,0.08738,1,1
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.03245,0.092044,0.10506,1,1
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.013465,0.091494,0.091201,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0083534,0.084844,0.086299,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.041967,0.084552,0.063856,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.0083534,0.084293,0.09966,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0062634,0.083789,0.091299,1,1
2,GO INTERSTRAND CROSS LINK REPAIR,0.045624,0.070779,0.06841,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.017549,0.069687,0.08888,1,1
2,GO MRNA PROCESSING,0.020205,0.067649,0.06358,1,1
2,GO RNA SPLICING,0.015953,0.063078,0.066395,1,1
2,GO PROTEIN ACETYLATION,0.011904,0.060701,0.059436,1,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.044685,0.050101,0.047045,1,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,4.1112e-06,1.2701,1.1307,1,1
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00012964,0.8674,0.66755,1,1
3,GO CYTIDINE TO URIDINE EDITING,0.00030804,0.75149,0.63041,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,5.9841e-06,0.75103,0.59634,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,7.547e-05,0.74274,0.68595,1,1
3,GO HISTAMINE SECRETION,2.8077e-06,0.70099,0.69335,1,1
3,GO LIPID DROPLET FORMATION,4.1112e-06,0.68312,0.64627,1,1
3,GO TOLERANCE INDUCTION,0.00016023,0.67628,0.59641,1,1
3,GO EOSINOPHIL CHEMOTAXIS,6.0504e-05,0.66143,0.50601,1,1
3,GO SEROTONIN METABOLIC PROCESS,1.7118e-05,0.6427,0.64502,1,1
3,GO RESPONSE TO IMMOBILIZATION STRESS,1.4039e-05,0.63619,0.47988,1,1
3,GO EOSINOPHIL MIGRATION,0.00012512,0.62288,0.46883,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00028792,0.61796,0.46172,1,1
3,GO HISTAMINE TRANSPORT,5.2837e-06,0.61771,0.63475,1,1
3,GO RESPONSE TO INTERFERON BETA,0.001872,0.59599,0.41556,1,1
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,4.6597e-05,0.59308,0.49074,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00032948,0.59093,0.48715,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0028957,0.58718,0.3847,1,1
3,GO RESPONSE TO TYPE I INTERFERON,8.7323e-05,0.58387,0.52479,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0010859,0.57127,0.45273,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00055855,0.57016,0.44165,1,1
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,7.3528e-06,0.56359,0.56606,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.023741,0.55186,0.28443,1,1
3,GO DETECTION OF OTHER ORGANISM,2.3418e-05,0.54486,0.51061,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.017137,0.54382,0.37041,1,1
3,GO KETONE CATABOLIC PROCESS,6.0504e-05,0.53568,0.49072,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00054072,0.53438,0.47051,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.1702e-06,0.53172,0.52067,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,0.00016023,0.52905,0.42839,1,1
3,GO REGULATION OF PLATELET AGGREGATION,6.5149e-05,0.52876,0.4638,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,8.1192e-05,0.52313,0.49496,1,1
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,9.3916e-06,0.52056,0.48606,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,8.3127e-06,0.51746,0.48251,1,1
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.001662,0.51313,0.3721,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00052342,0.51192,0.38703,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,0.00014418,0.50517,0.52597,1,1
3,GO O GLYCAN PROCESSING,6.7728e-06,0.50443,0.44832,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00065623,0.50336,0.35955,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.6174e-05,0.49563,0.4607,1,1
3,GO RENAL ABSORPTION,0.00054072,0.49553,0.48977,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,5.4121e-05,0.49511,0.48864,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,3.6228e-06,0.4886,0.46425,1,1
3,GO NEGATIVE REGULATION OF ANOIKIS,0.00019079,0.48576,0.57577,1,1
3,GO RESPONSE TO COLD,1.6455e-05,0.4803,0.39486,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0006154,0.4785,0.36428,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.001228,0.47707,0.33636,1,1
3,GO GERMINAL CENTER FORMATION,0.00055855,0.47296,0.45279,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010092,0.47279,0.44816,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00098941,0.47018,0.46243,1,1
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00031859,0.46824,0.43125,1,1
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0064317,0.46211,0.2931,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.7145e-05,0.45949,0.47566,1,1
3,GO CELLULAR RESPONSE TO ZINC ION,0.042857,0.45632,0.4566,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,1.349e-05,0.45453,0.43092,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0006154,0.45331,0.39152,1,1
3,GO LEYDIG CELL DIFFERENTIATION,0.00098941,0.44882,0.4067,1,1
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00013433,0.44675,0.50318,1,1
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00025131,0.44608,0.48542,1,1
3,GO TOXIN METABOLIC PROCESS,5.0226e-05,0.44581,0.41931,1,1
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.001228,0.44317,0.35288,1,1
3,GO REGULATION OF VASCULOGENESIS,0.00063551,0.44133,0.41837,1,1
3,GO EPITHELIAL CELL MORPHOGENESIS,0.00074557,0.44121,0.37297,1,1
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.0034322,0.44002,0.43641,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00087311,0.43969,0.3054,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,1.4609e-05,0.43957,0.52505,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,5.9841e-06,0.43676,0.42966,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00012074,0.43498,0.50834,1,1
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,3.1888e-05,0.4344,0.40361,1,1
3,GO LIPOXYGENASE PATHWAY,0.0054795,0.43431,0.33435,1,1
3,GO INTESTINAL ABSORPTION,4.6623e-06,0.43417,0.45355,1,1
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00017796,0.43324,0.47563,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00014935,0.43307,0.40916,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00026903,0.43283,0.34995,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,9.7346e-05,0.43262,0.40048,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0021689,0.43249,0.31327,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,8.7323e-05,0.42973,0.4227,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.0073e-05,0.42936,0.34589,1,1
3,GO REGULATION OF WATER LOSS VIA SKIN,0.0001165,0.42859,0.41705,1,1
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.013139,0.42809,0.31317,1,1
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0032441,0.42492,0.28665,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.1112e-06,0.42438,0.54379,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00087311,0.41995,0.39719,1,1
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0083534,0.41948,0.33016,1,1
3,GO REGULATION OF PLATELET ACTIVATION,6.0504e-05,0.41792,0.38281,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00023468,0.41758,0.4261,1,1
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00055855,0.41635,0.43569,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,5.2139e-05,0.41484,0.37128,1,1
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.013139,0.41161,0.28321,1,1
3,GO RESPONSE TO EPINEPHRINE,0.0083534,0.41009,0.32358,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,6.5896e-07,0.40629,0.44932,1,1
3,GO B CELL APOPTOTIC PROCESS,3.8583e-05,0.40366,0.39471,1,1
3,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00063551,0.40191,0.29814,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,5.6174e-05,0.40132,0.36782,1,1
3,GO RESPONSE TO REDOX STATE,0.0017123,0.39936,0.30242,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0017641,0.39895,0.29734,1,1
3,GO RESPONSE TO MUSCLE STRETCH,0.00044439,0.3961,0.38948,1,1
3,GO REGULATION OF NEURON MATURATION,0.00052342,0.39567,0.32495,1,1
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00050664,0.3942,0.40955,1,1
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00092958,0.3936,0.25741,1,1
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00026003,0.39276,0.32235,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00090094,0.39245,0.347,1,1
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00038934,0.39114,0.33296,1,1
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00044439,0.39085,0.31147,1,1
3,GO INSEMINATION,0.0025817,0.39037,0.34197,1,1
3,GO RESPONSE TO DIETARY EXCESS,0.00052342,0.3899,0.36061,1,1
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0013457,0.38964,0.32896,1,1
3,GO LIVER MORPHOGENESIS,0.00031859,0.38951,0.38443,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0025083,0.38745,0.26665,1,1
3,GO LUNG CELL DIFFERENTIATION,0.00098941,0.38716,0.42022,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00069957,0.38684,0.29055,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00019079,0.38575,0.32693,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0013054,0.38567,0.24782,1,1
3,GO CELLULAR DEFENSE RESPONSE,6.0504e-05,0.38294,0.31042,1,1
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00063551,0.38139,0.40116,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7343e-05,0.38112,0.41551,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,4.4878e-05,0.38111,0.35734,1,1
3,GO ZYMOGEN ACTIVATION,0.0047853,0.3797,0.2521,1,1
3,GO RESPONSE TO WATER,0.0034322,0.37937,0.30652,1,1
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0013054,0.37898,0.29834,1,1
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00081984,0.37898,0.43238,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.03245,0.37885,0.24271,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0006154,0.37839,0.27505,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0056288,0.37777,0.34385,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,3.7145e-05,0.37632,0.35977,1,1
3,GO CELLULAR RESPONSE TO COPPER ION,0.010245,0.37592,0.51209,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,3.3132e-05,0.37553,0.34416,1,1
3,GO MITOCHONDRIAL DEPOLARIZATION,3.1888e-05,0.37551,0.33391,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00057693,0.37421,0.28381,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,1.5816e-05,0.37408,0.35829,1,1
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0049174,0.37378,0.34709,1,1
3,GO ADRENAL GLAND DEVELOPMENT,6.2786e-05,0.37354,0.43367,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0012662,0.37281,0.32258,1,1
3,GO MATURE B CELL DIFFERENTIATION,0.001191,0.37274,0.34386,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,2.0833e-05,0.37151,0.31621,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0006154,0.37136,0.26547,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0011549,0.36919,0.28934,1,1
3,GO IMMUNOGLOBULIN SECRETION,0.00019753,0.36918,0.34903,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.0011199,0.36862,0.26072,1,1
3,GO LIPID TRANSLOCATION,3.7145e-05,0.36702,0.3066,1,1
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.016734,0.36436,0.33361,1,1
3,GO RESPONSE TO COPPER ION,0.00037661,0.36221,0.49199,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.014486,0.3613,0.23879,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0015653,0.3585,0.26253,1,1
3,GO REGULATION OF EXOSOMAL SECRETION,4.6597e-05,0.35826,0.30916,1,1
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,1.4609e-05,0.35719,0.35541,1,1
3,GO REGULATION OF RESPIRATORY BURST,4.4712e-06,0.35648,0.40669,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,2.0033e-05,0.3562,0.32298,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,0.00014935,0.3556,0.39068,1,1
3,GO REGULATION OF ANOIKIS,0.00067758,0.35555,0.40976,1,1
3,GO GALACTOSE METABOLIC PROCESS,0.027188,0.3554,0.24718,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.029719,0.35536,0.23341,1,1
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.004408,0.35536,0.37706,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00063551,0.35328,0.29118,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0028141,0.35306,0.30219,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0047853,0.35294,0.27024,1,1
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.0073363,0.35059,0.34233,1,1
3,GO HEART INDUCTION,0.02843,0.34981,0.28264,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00050664,0.34972,0.30404,1,1
3,GO PARENTAL BEHAVIOR,0.021165,0.34839,0.23753,1,1
3,GO MAGNESIUM ION TRANSPORT,0.00017186,0.34741,0.28349,1,1
3,GO PHOSPHOLIPID EFFLUX,0.0032441,0.34741,0.22593,1,1
3,GO INTESTINAL LIPID ABSORPTION,0.00028792,0.34683,0.4207,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0056288,0.34679,0.29344,1,1
3,GO BONE RESORPTION,7.2754e-05,0.3465,0.27313,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,0.00023468,0.34594,0.2953,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.0001165,0.34549,0.43131,1,1
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0010528,0.34525,0.32951,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00087311,0.34434,0.292,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.046579,0.34353,0.19017,1,1
3,GO KERATINOCYTE DEVELOPMENT,0.0017123,0.34283,0.3801,1,1
3,GO MYOBLAST FUSION,0.0013872,0.34153,0.25463,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00045924,0.34135,0.35044,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,8.4205e-05,0.33996,0.29022,1,1
3,GO RESPONSE TO INTERFERON GAMMA,0.00084609,0.33976,0.28174,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0073363,0.3396,0.29285,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,0.0013054,0.33879,0.24568,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.01282,0.33821,0.18094,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0023671,0.33761,0.35314,1,1
3,GO RESPONSE TO INTERLEUKIN 2,3.4421e-05,0.33761,0.30309,1,1
3,GO REGULATION OF B CELL PROLIFERATION,2.4346e-05,0.33755,0.3267,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00019079,0.3375,0.3512,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0056288,0.33734,0.27589,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0017641,0.33584,0.24201,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.0038387,0.33461,0.25162,1,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.6455e-05,0.33435,0.27437,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0060989,0.33426,0.25576,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.4421e-05,0.33205,0.33312,1,1
3,GO QUINONE METABOLIC PROCESS,0.0017641,0.3319,0.33455,1,1
3,GO VIRAL GENOME REPLICATION,0.00098941,0.33156,0.23005,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00036427,0.33102,0.28814,1,1
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,5.8301e-05,0.33063,0.37247,1,1
3,GO REGULATION OF TISSUE REMODELING,0.0001165,0.33003,0.2755,1,1
3,GO VITAMIN D METABOLIC PROCESS,0.00019079,0.32987,0.29259,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0031536,0.32974,0.29778,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.045624,0.32927,0.25089,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0016129,0.32907,0.30424,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,4.4878e-05,0.32844,0.27764,1,1
3,GO TISSUE REMODELING,0.00032948,0.32842,0.23141,1,1
3,GO DEFENSE RESPONSE TO VIRUS,0.0012662,0.32768,0.22303,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.013465,0.32647,0.21943,1,1
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.013e-05,0.32643,0.36626,1,1
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00063551,0.32599,0.31313,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.017549,0.32563,0.21982,1,1
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0001547,0.32535,0.38152,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,0.00024286,0.32526,0.24502,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.7323e-05,0.32495,0.3257,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0011199,0.32462,0.34391,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0028957,0.32444,0.25485,1,1
3,GO NEURONAL ACTION POTENTIAL,0.00057693,0.32443,0.4066,1,1
3,GO ETHER METABOLIC PROCESS,0.0056288,0.32382,0.20886,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,3.0689e-05,0.32373,0.29721,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.2754e-05,0.32372,0.29321,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00044439,0.32202,0.29638,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0015189,0.32153,0.2019,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.046579,0.32098,0.23312,1,1
3,GO RESPONSE TO CORTICOSTERONE,0.0057817,0.31983,0.25868,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,3.0689e-05,0.31964,0.29994,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0014738,0.31855,0.26648,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.010773,0.31846,0.21396,1,1
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00026003,0.3174,0.31157,1,1
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0034322,0.31645,0.23516,1,1
3,GO PROTEIN DEMANNOSYLATION,0.00035231,0.31641,0.28714,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0021062,0.31633,0.22686,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00025131,0.31567,0.30021,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00017186,0.31542,0.28083,1,1
3,GO PLASMA MEMBRANE FUSION,0.0021689,0.31527,0.23841,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.014138,0.31483,0.22471,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.001191,0.31452,0.25655,1,1
3,GO RELAXATION OF CARDIAC MUSCLE,0.0041716,0.31374,0.31395,1,1
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.0012662,0.31261,0.27105,1,1
3,GO LUNG ALVEOLUS DEVELOPMENT,5.6174e-05,0.31255,0.31017,1,1
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0085714,0.31137,0.3067,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.040234,0.31092,0.17432,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.9418e-06,0.31078,0.34347,1,1
3,GO SECONDARY METABOLIC PROCESS,0.0026572,0.31054,0.24201,1,1
3,GO RESPONSE TO MAGNESIUM ION,0.00087311,0.31049,0.3566,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0011199,0.30993,0.38213,1,1
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.019283,0.30989,0.33531,1,1
3,GO RESPONSE TO STEROL DEPLETION,0.00026903,0.30929,0.32208,1,1
3,GO EPITHELIAL CELL FATE COMMITMENT,0.012508,0.30845,0.25182,1,1
3,GO ANOIKIS,0.00017186,0.3084,0.3417,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00040247,0.30767,0.28369,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00047456,0.30748,0.24431,1,1
3,GO VASODILATION,0.01282,0.30745,0.18962,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.027803,0.30744,0.24944,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0038387,0.30712,0.26985,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0034322,0.30697,0.22931,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,0.00032948,0.30632,0.30171,1,1
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.010245,0.30514,0.25935,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00017186,0.30435,0.33252,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,7.8282e-05,0.30312,0.3084,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.045624,0.30281,0.25849,1,1
3,GO HYPOTHALAMUS DEVELOPMENT,0.001662,0.30275,0.24875,1,1
3,GO INTERLEUKIN 12 PRODUCTION,3.3132e-05,0.30274,0.29195,1,1
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0015189,0.30233,0.30613,1,1
3,GO TRNA CATABOLIC PROCESS,0.013139,0.30221,0.30519,1,1
3,GO RESPONSE TO CAFFEINE,0.001986,0.30171,0.24632,1,1
3,GO MAST CELL ACTIVATION,9.389e-05,0.30157,0.27214,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.00012964,0.30146,0.25428,1,1
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,2.8418e-05,0.3008,0.272,1,1
3,GO SEQUESTERING OF ACTIN MONOMERS,0.036948,0.30041,0.27765,1,1
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00029782,0.29983,0.22861,1,1
3,GO MAST CELL MEDIATED IMMUNITY,0.0010528,0.29946,0.24853,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0017123,0.29932,0.28624,1,1
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0020453,0.29925,0.18282,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00010462,0.29923,0.31128,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00021909,0.29911,0.21892,1,1
3,GO ADHESION OF SYMBIONT TO HOST,0.00353,0.29903,0.34304,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00014418,0.29804,0.24345,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0094949,0.29788,0.33129,1,1
3,GO REGULATION OF BONE REMODELING,0.0001165,0.29667,0.29577,1,1
3,GO L PHENYLALANINE METABOLIC PROCESS,0.0090226,0.2966,0.2619,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.00041602,0.29635,0.2925,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00028792,0.29621,0.24778,1,1
3,GO REGULATION OF TRANSPOSITION,0.0081404,0.29572,0.27152,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0037331,0.29557,0.192,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00026003,0.29522,0.30086,1,1
3,GO OSTEOBLAST PROLIFERATION,0.00079435,0.29511,0.27468,1,1
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0066042,0.29429,0.30505,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00037661,0.29423,0.30561,1,1
3,GO T CELL MEDIATED IMMUNITY,0.0021062,0.29413,0.2265,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0021689,0.29333,0.1869,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0015653,0.29245,0.32655,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00012512,0.29239,0.27632,1,1
3,GO OPTIC NERVE DEVELOPMENT,0.0021062,0.29177,0.33352,1,1
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.024288,0.29152,0.2701,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00057693,0.29129,0.20498,1,1
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00029782,0.29045,0.23051,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.017549,0.29022,0.21733,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00036427,0.2893,0.32337,1,1
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,8.1192e-05,0.2892,0.25015,1,1
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0041716,0.28865,0.2728,1,1
3,GO ICOSANOID METABOLIC PROCESS,0.00034072,0.28796,0.23717,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00017796,0.2879,0.22418,1,1
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.00074557,0.28774,0.3118,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00012074,0.28755,0.29642,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0037331,0.28686,0.33617,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0045306,0.28658,0.1932,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0017641,0.28651,0.28619,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.012508,0.28621,0.17224,1,1
3,GO B CELL HOMEOSTASIS,0.00021909,0.28615,0.24911,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,7.8282e-05,0.28611,0.28536,1,1
3,GO INTERLEUKIN 10 PRODUCTION,0.00010092,0.2859,0.25942,1,1
3,GO TRANSPOSITION,0.001662,0.28564,0.30253,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0023671,0.2854,0.25936,1,1
3,GO BONE REMODELING,0.00059588,0.28503,0.23615,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0001165,0.28492,0.27314,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.001191,0.28451,0.18635,1,1
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.036948,0.28437,0.23002,1,1
3,GO EXTRACELLULAR VESICLE BIOGENESIS,9.0551e-05,0.28383,0.23236,1,1
3,GO LYTIC VACUOLE ORGANIZATION,4.1112e-06,0.28372,0.25881,1,1
3,GO PHAGOSOME ACIDIFICATION,5.6174e-05,0.28322,0.24588,1,1
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0056288,0.28318,0.20167,1,1
3,GO METHIONINE METABOLIC PROCESS,0.0027346,0.28315,0.19924,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.010506,0.2831,0.23902,1,1
3,GO REGULATION OF DENDRITE EXTENSION,0.001191,0.28289,0.3579,1,1
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0037331,0.28275,0.24517,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,3.3132e-05,0.28251,0.23279,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,0.0021062,0.28146,0.22077,1,1
3,GO REGULATION OF RECEPTOR CLUSTERING,0.03245,0.28085,0.27427,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.023205,0.28074,0.25016,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0025083,0.28036,0.22338,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,0.0028141,0.28033,0.22263,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00087311,0.28001,0.23327,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0010528,0.27992,0.2093,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.025414,0.27955,0.294,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0020453,0.27949,0.26971,1,1
3,GO POLYOL TRANSPORT,0.0057817,0.27931,0.20263,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0022992,0.27897,0.24533,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00081984,0.27864,0.23407,1,1
3,GO APICAL JUNCTION ASSEMBLY,0.00010092,0.27855,0.29454,1,1
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0025083,0.27816,0.21029,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.021165,0.27768,0.29884,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.0015653,0.27716,0.24482,1,1
3,GO REGULATION OF ICOSANOID SECRETION,2.4346e-05,0.27692,0.31193,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0042883,0.27611,0.2099,1,1
3,GO RESPIRATORY BURST,0.0025083,0.27503,0.22702,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.001986,0.275,0.17952,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00041602,0.27459,0.30809,1,1
3,GO CELL KILLING,0.00013433,0.27435,0.21532,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00057693,0.27433,0.30792,1,1
3,GO CAMP BIOSYNTHETIC PROCESS,0.029719,0.27423,0.21294,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.0081404,0.27417,0.21032,1,1
3,GO INTERLEUKIN 8 PRODUCTION,0.0015653,0.27402,0.20882,1,1
3,GO REGULATION OF CELL KILLING,0.00054072,0.27395,0.24695,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00047456,0.27367,0.24734,1,1
3,GO MUSCLE ATROPHY,0.0083534,0.27332,0.24101,1,1
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,9.7346e-05,0.27254,0.25583,1,1
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0023671,0.27233,0.28063,1,1
3,GO REGULATION OF ACROSOME REACTION,0.016339,0.27219,0.20828,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.009256,0.27199,0.19941,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00025131,0.27195,0.20652,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0073363,0.27182,0.26162,1,1
3,GO RESPONSE TO VIRUS,0.001986,0.27174,0.18532,1,1
3,GO HEART TRABECULA FORMATION,0.011904,0.2712,0.27294,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.012508,0.27114,0.19768,1,1
3,GO B CELL PROLIFERATION,4.6597e-05,0.27108,0.25023,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0069616,0.27077,0.20025,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0036303,0.27042,0.22544,1,1
3,GO SUPEROXIDE ANION GENERATION,0.011612,0.27009,0.21376,1,1
3,GO HAIR CELL DIFFERENTIATION,0.00024286,0.26977,0.22824,1,1
3,GO ENDOCARDIUM DEVELOPMENT,0.010773,0.26947,0.25881,1,1
3,GO CORNIFICATION,0.00010845,0.26926,0.27346,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0018173,0.26892,0.19987,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00014935,0.26837,0.28262,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0054795,0.26754,0.18721,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00079435,0.26733,0.27431,1,1
3,GO RETINAL METABOLIC PROCESS,0.017549,0.26692,0.28786,1,1
3,GO GLYCOSYLATION,0.00019079,0.26665,0.22127,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00013433,0.26609,0.23421,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0039469,0.26601,0.20522,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.2754e-05,0.26593,0.29635,1,1
3,GO DIGESTIVE SYSTEM PROCESS,0.00012964,0.26552,0.23076,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.001228,0.26414,0.23025,1,1
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.012508,0.264,0.19054,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0007696,0.26372,0.17104,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0026572,0.26328,0.21112,1,1
3,GO STEROL METABOLIC PROCESS,0.00035231,0.26244,0.19739,1,1
3,GO RESPONSE TO MINERALOCORTICOID,0.0099891,0.26243,0.1904,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,0.00057693,0.26224,0.27952,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0047853,0.26189,0.1806,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00057693,0.26147,0.19058,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00069957,0.26141,0.23438,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0010206,0.26131,0.19539,1,1
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0017641,0.26101,0.22193,1,1
3,GO REGULATION OF COAGULATION,0.0097392,0.26097,0.18236,1,1
3,GO UBIQUINONE METABOLIC PROCESS,0.00050664,0.26091,0.18076,1,1
3,GO HOMOTYPIC CELL CELL ADHESION,0.00024286,0.26086,0.26354,1,1
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.010245,0.26063,0.25208,1,1
3,GO FOAM CELL DIFFERENTIATION,0.00045924,0.26026,0.28773,1,1
3,GO REGULATION OF B CELL ACTIVATION,5.8301e-05,0.26019,0.2384,1,1
3,GO PARTURITION,0.034637,0.26012,0.2373,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00035231,0.26001,0.30268,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0038387,0.25991,0.16588,1,1
3,GO INNATE IMMUNE RESPONSE,0.00052342,0.25971,0.18883,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00092958,0.25943,0.21174,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.013465,0.25924,0.19093,1,1
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0025817,0.25915,0.22813,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.001228,0.25871,0.2508,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0033369,0.25869,0.22297,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0017641,0.25861,0.33377,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0025817,0.25794,0.16911,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00041602,0.25782,0.2277,1,1
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0041716,0.25773,0.20439,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0013054,0.25757,0.22957,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.012203,0.25702,0.29682,1,1
3,GO DISACCHARIDE METABOLIC PROCESS,0.010773,0.2567,0.21133,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.0045306,0.2567,0.18242,1,1
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00012512,0.25643,0.2417,1,1
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.02843,0.25635,0.17458,1,1
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.02843,0.25622,0.15905,1,1
3,GO KERATINIZATION,8.1192e-05,0.25569,0.2515,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00095906,0.25532,0.26721,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0014738,0.25481,0.17621,1,1
3,GO GDP METABOLIC PROCESS,0.0075304,0.25339,0.25695,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00081984,0.25336,0.18434,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00023468,0.25325,0.23972,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,5.4121e-05,0.25232,0.23154,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00019753,0.25207,0.26338,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013872,0.2519,0.37392,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00040247,0.25143,0.18219,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00353,0.25094,0.19974,1,1
3,GO NERVE DEVELOPMENT,0.0014738,0.25047,0.22338,1,1
3,GO SNARE COMPLEX ASSEMBLY,0.019739,0.25018,0.16979,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013054,0.2501,0.19511,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0011549,0.24984,0.25175,1,1
3,GO LEUKOCYTE PROLIFERATION,0.0007696,0.24956,0.17804,1,1
3,GO IMMUNE EFFECTOR PROCESS,0.00079435,0.24917,0.18159,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00034072,0.24908,0.22889,1,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.025414,0.24904,0.16842,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.010245,0.24903,0.14492,1,1
3,GO STEROID METABOLIC PROCESS,0.00012512,0.24882,0.20247,1,1
3,GO LIPID DROPLET ORGANIZATION,8.4205e-05,0.24874,0.25727,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0060989,0.24806,0.18695,1,1
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0028141,0.24805,0.19224,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00032948,0.24784,0.19758,1,1
3,GO ACTIN FILAMENT SEVERING,0.014841,0.24766,0.25454,1,1
3,GO PROTEIN KINASE C SIGNALING,0.0022992,0.24714,0.26391,1,1
3,GO STEROL HOMEOSTASIS,0.0025083,0.24672,0.1769,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.00059588,0.24661,0.21234,1,1
3,GO WATER HOMEOSTASIS,0.00052342,0.24651,0.23019,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,6.2786e-05,0.24649,0.24819,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.004408,0.24602,0.17848,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.001228,0.24586,0.25361,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00028792,0.24566,0.23659,1,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00087311,0.24561,0.23472,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00067758,0.24501,0.20397,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,3.3132e-05,0.24473,0.31751,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0017123,0.24433,0.20888,1,1
3,GO TRANSFERRIN TRANSPORT,4.1617e-05,0.24383,0.20703,1,1
3,GO INTEGRIN ACTIVATION,0.00022676,0.24334,0.25197,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00017796,0.24317,0.21997,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0011549,0.24256,0.18684,1,1
3,GO CYTOPLASM ORGANIZATION,0.0007696,0.2423,0.22023,1,1
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0010859,0.24218,0.20335,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00079435,0.24157,0.22177,1,1
3,GO SMOOTH MUSCLE CELL MIGRATION,0.041093,0.24117,0.14752,1,1
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00045924,0.241,0.22367,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,7.013e-05,0.24076,0.20876,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00026903,0.24021,0.24549,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00026003,0.24017,0.23203,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,0.00095906,0.23999,0.29119,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.00095906,0.23954,0.24804,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0013457,0.23916,0.19618,1,1
3,GO ESTROUS CYCLE,0.029068,0.23893,0.18636,1,1
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0014299,0.23879,0.27261,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,0.00031859,0.23864,0.20089,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00047456,0.23857,0.18945,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0062634,0.23847,0.15798,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00010845,0.2384,0.22283,1,1
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.0013457,0.23839,0.23692,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0064317,0.2383,0.2331,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0010528,0.23809,0.1954,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.001662,0.23798,0.18129,1,1
3,GO DIGESTION,0.00023468,0.23757,0.22526,1,1
3,GO CRANIAL NERVE DEVELOPMENT,0.00353,0.23744,0.21054,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0018173,0.23724,0.2229,1,1
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.0099891,0.23698,0.18529,1,1
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.03939,0.23665,0.1806,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00050664,0.23642,0.20868,1,1
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0038387,0.23621,0.19331,1,1
3,GO NATURAL KILLER CELL PROLIFERATION,0.009256,0.23617,0.27016,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0010528,0.23576,0.17107,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.027188,0.23566,0.16479,1,1
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.027803,0.23543,0.24491,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.011047,0.23525,0.19916,1,1
3,GO REGULATION OF FATTY ACID TRANSPORT,0.00010092,0.23523,0.25894,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.014841,0.23517,0.22671,1,1
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0046564,0.23479,0.22009,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.00079435,0.23473,0.18365,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00019753,0.23468,0.19372,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.0028957,0.23437,0.2023,1,1
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0049174,0.23421,0.18748,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.007729,0.23412,0.18824,1,1
3,GO POSITIVE CHEMOTAXIS,0.0085714,0.23404,0.14645,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0015653,0.2338,0.30869,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.017137,0.23359,0.15346,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.010773,0.23326,0.21052,1,1
3,GO CELL CHEMOTAXIS,0.00057693,0.23292,0.17972,1,1
3,GO SYNCYTIUM FORMATION,0.0056288,0.23287,0.17126,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0024367,0.23286,0.18898,1,1
3,GO VACUOLAR ACIDIFICATION,0.00012074,0.23271,0.20445,1,1
3,GO REGULATION OF CELL CELL ADHESION,0.00095906,0.23263,0.18154,1,1
3,GO RESPONSE TO GROWTH HORMONE,0.0011199,0.23261,0.22519,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.010506,0.23253,0.16795,1,1
3,GO INTERLEUKIN 6 PRODUCTION,0.00023468,0.23249,0.19589,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,0.0025817,0.2322,0.16819,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,0.0041716,0.23219,0.15906,1,1
3,GO GRANULOCYTE MIGRATION,0.0014299,0.23178,0.15458,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0090226,0.23171,0.18542,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0010859,0.23164,0.18505,1,1
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.00010092,0.23123,0.30186,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.7118e-05,0.23109,0.23722,1,1
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00069957,0.2309,0.26093,1,1
3,GO CERAMIDE METABOLIC PROCESS,0.00032948,0.23081,0.18255,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.012203,0.23068,0.14569,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00055855,0.23058,0.22665,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00014418,0.23033,0.20562,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,0.0013054,0.23011,0.19687,1,1
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.011612,0.23007,0.16312,1,1
3,GO ENDOTHELIUM DEVELOPMENT,0.0046564,0.23006,0.15755,1,1
3,GO ENERGY HOMEOSTASIS,0.0024367,0.2299,0.21322,1,1
3,GO GRANULOCYTE CHEMOTAXIS,0.0013872,0.22982,0.14479,1,1
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0097392,0.22958,0.21852,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,0.00014935,0.22917,0.19124,1,1
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.02166,0.22869,0.13627,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.012508,0.22863,0.24193,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00021167,0.22861,0.18629,1,1
3,GO INTERFERON ALPHA PRODUCTION,0.00029782,0.22845,0.23012,1,1
3,GO BILE ACID METABOLIC PROCESS,0.00030804,0.22831,0.21846,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.00055855,0.22827,0.2043,1,1
3,GO POSITIVE REGULATION OF HEART RATE,0.0042883,0.22816,0.25858,1,1
3,GO CHEMOKINE PRODUCTION,0.0050528,0.22778,0.17072,1,1
3,GO MEGAKARYOCYTE DEVELOPMENT,0.031059,0.22742,0.23067,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00026903,0.22733,0.19319,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0054795,0.22716,0.24724,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.004408,0.22716,0.16565,1,1
3,GO ORGANELLE MEMBRANE FUSION,0.010773,0.22698,0.13861,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0041716,0.22685,0.1701,1,1
3,GO LEUKOCYTE CHEMOTAXIS,0.00098941,0.22647,0.17025,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0017123,0.22611,0.18151,1,1
3,GO RESPONSE TO TUMOR CELL,0.0047853,0.22586,0.20182,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00055855,0.22586,0.19669,1,1
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.029719,0.22563,0.18676,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00042998,0.22532,0.18717,1,1
3,GO REGULATION OF RESPONSE TO FOOD,0.029719,0.22493,0.1164,1,1
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.045624,0.22483,0.21844,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.019283,0.22452,0.15241,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00072223,0.22446,0.20375,1,1
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0028141,0.22445,0.16925,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0031536,0.22444,0.17962,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0041716,0.22434,0.18051,1,1
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.011326,0.22424,0.19297,1,1
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00353,0.22397,0.2855,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.00098941,0.22368,0.18067,1,1
3,GO REGULATION OF FERTILIZATION,0.0024367,0.22356,0.18565,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0045306,0.22311,0.19286,1,1
3,GO KERATINOCYTE DIFFERENTIATION,0.00034072,0.22279,0.20215,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00031859,0.22267,0.1977,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.001872,0.22242,0.20342,1,1
3,GO DOPAMINE METABOLIC PROCESS,0.0033369,0.22238,0.24964,1,1
3,GO SECRETION BY TISSUE,0.0057817,0.22219,0.18979,1,1
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0013054,0.22202,0.21449,1,1
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0015653,0.22202,0.29195,1,1
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.046579,0.22183,0.17764,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0025083,0.22171,0.16808,1,1
3,GO LEUKOCYTE MIGRATION,0.0012662,0.22154,0.1759,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00022676,0.22148,0.26753,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.00059588,0.22127,0.20774,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0090226,0.22109,0.14319,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,6.2786e-05,0.22105,0.25855,1,1
3,GO PHOSPHOLIPID TRANSPORT,0.00027832,0.22071,0.18718,1,1
3,GO DEFENSE RESPONSE,0.00047456,0.22069,0.16948,1,1
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0025083,0.22067,0.37566,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00065623,0.22031,0.19027,1,1
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00057693,0.21998,0.19762,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.035393,0.21993,0.14661,1,1
3,GO AMYLOID BETA FORMATION,0.017549,0.21989,0.16808,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00037661,0.21974,0.16342,1,1
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0006154,0.21962,0.189,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0013872,0.21929,0.20076,1,1
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0007696,0.21869,0.19832,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0031536,0.21831,0.15109,1,1
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00026903,0.21825,0.19296,1,1
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.040234,0.21801,0.18628,1,1
3,GO NOTCH SIGNALING PATHWAY,0.00057693,0.21794,0.18703,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00098941,0.21763,0.20565,1,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0064317,0.21745,0.23717,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0017123,0.21731,0.19965,1,1
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0045306,0.2171,0.30247,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00035231,0.21677,0.22192,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.00019079,0.21661,0.20643,1,1
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.041093,0.21651,0.14496,1,1
3,GO DIOL BIOSYNTHETIC PROCESS,0.0028141,0.21614,0.21131,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0039469,0.21567,0.16648,1,1
3,GO ALANINE TRANSPORT,0.040234,0.21532,0.14551,1,1
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00072223,0.21499,0.29702,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0083534,0.21492,0.19931,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0010206,0.21448,0.19234,1,1
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0013872,0.21401,0.18231,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.6455e-05,0.21377,0.1971,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00098941,0.21372,0.15015,1,1
3,GO REGULATION OF AMYLOID BETA FORMATION,0.031748,0.21358,0.17513,1,1
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.012203,0.21355,0.17354,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.0031536,0.21353,0.19238,1,1
3,GO GLIAL CELL APOPTOTIC PROCESS,0.014841,0.21351,0.23817,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,9.389e-05,0.21349,0.20107,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.013798,0.21311,0.20728,1,1
3,GO MYOTUBE DIFFERENTIATION,0.00084609,0.21295,0.17725,1,1
3,GO PROTEIN DEGLYCOSYLATION,0.00081984,0.21274,0.26606,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0021062,0.21209,0.16556,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0030654,0.21208,0.16014,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0013872,0.21199,0.17365,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00098941,0.21185,0.24922,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0032441,0.21161,0.18906,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.018836,0.21158,0.19726,1,1
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00021909,0.21102,0.19063,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0085714,0.21089,0.17037,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00030804,0.21017,0.22936,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,2.0033e-05,0.21012,0.21071,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0034322,0.20954,0.14582,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00090094,0.20951,0.20336,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0017641,0.2095,0.16668,1,1
3,GO WHITE FAT CELL DIFFERENTIATION,0.0017641,0.20931,0.21241,1,1
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0040578,0.20926,0.16376,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.018398,0.20916,0.17835,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,0.0013054,0.20891,0.14662,1,1
3,GO MUSCLE HYPERTROPHY,0.0024367,0.20864,0.16542,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,0.0022992,0.20847,0.16749,1,1
3,GO NUCLEOTIDE TRANSPORT,0.00038934,0.20817,0.17161,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00018427,0.20796,0.19261,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.011612,0.20762,0.14818,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.0027346,0.20748,0.17766,1,1
3,GO RESPONSE TO INTERLEUKIN 6,0.0083534,0.2073,0.16401,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0010528,0.2069,0.1739,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0050528,0.20687,0.18726,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00019079,0.20665,0.15807,1,1
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.00020448,0.20664,0.19545,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017549,0.20649,0.21376,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.004408,0.20621,0.1539,1,1
3,GO SKIN DEVELOPMENT,0.0013872,0.20621,0.1601,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0034322,0.20618,0.14749,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.044685,0.20609,0.12248,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00059588,0.20596,0.20558,1,1
3,GO T CELL PROLIFERATION,0.001228,0.20568,0.17661,1,1
3,GO SPHINGOLIPID METABOLIC PROCESS,0.00014418,0.20566,0.20113,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0028957,0.20501,0.13608,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0010206,0.20473,0.1589,1,1
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.0053338,0.20454,0.28134,1,1
3,GO RESPONSE TO CYTOKINE,0.001662,0.20436,0.14532,1,1
3,GO CYTOKINE PRODUCTION,0.0016129,0.20422,0.15997,1,1
3,GO NEURON MATURATION,0.0049174,0.20385,0.20024,1,1
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.011612,0.20337,0.17351,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0051916,0.20332,0.13908,1,1
3,GO REGULATION OF DOPAMINE SECRETION,0.037747,0.20297,0.32466,1,1
3,GO SIGNAL PEPTIDE PROCESSING,0.00090094,0.20295,0.28289,1,1
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0075304,0.20237,0.1611,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0031536,0.20166,0.19381,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.018836,0.20154,0.18291,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.004408,0.20112,0.20545,1,1
3,GO REGULATION OF APPETITE,0.0067808,0.20084,0.13756,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0075304,0.2007,0.14492,1,1
3,GO ACUTE PHASE RESPONSE,0.0025817,0.20065,0.17692,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0046564,0.20063,0.13662,1,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.024846,0.20061,0.13583,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.02166,0.20034,0.19159,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.014486,0.20031,0.15001,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.5308e-05,0.20027,0.22727,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00055855,0.19994,0.19009,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0030654,0.19991,0.1613,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.009256,0.19981,0.17281,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,9.0551e-05,0.19975,0.18605,1,1
3,GO MECHANORECEPTOR DIFFERENTIATION,0.00026003,0.19969,0.19474,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.017549,0.19935,0.14738,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00025131,0.19923,0.17852,1,1
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.02268,0.19913,0.19677,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0013054,0.19889,0.16407,1,1
3,GO METANEPHROS MORPHOGENESIS,0.0053338,0.19869,0.19581,1,1
3,GO EPIDERMIS DEVELOPMENT,0.00079435,0.19854,0.16497,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.025994,0.1984,0.17377,1,1
3,GO MEMBRANE DEPOLARIZATION,0.0031536,0.19829,0.21737,1,1
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.0010528,0.19823,0.23289,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0051916,0.19816,0.16369,1,1
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.027803,0.19787,0.1607,1,1
3,GO STEROL BIOSYNTHETIC PROCESS,0.00035231,0.19786,0.18703,1,1
3,GO LIPID STORAGE,0.011047,0.1978,0.1542,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0085714,0.19767,0.14195,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.001986,0.19752,0.1518,1,1
3,GO AMINE METABOLIC PROCESS,6.0504e-05,0.19748,0.18701,1,1
3,GO LIPID LOCALIZATION,0.00040247,0.19732,0.16723,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.019739,0.19728,0.14597,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00019753,0.19706,0.20714,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00353,0.19699,0.25941,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,0.00092958,0.19696,0.17591,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0033369,0.1969,0.16392,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,0.001872,0.19652,0.15247,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.0019282,0.1964,0.23501,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00026003,0.19621,0.18502,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0034322,0.19613,0.16849,1,1
3,GO MULTICELLULAR ORGANISM AGING,0.00017796,0.1959,0.18883,1,1
3,GO LYMPHOCYTE MIGRATION,0.010506,0.19581,0.13539,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00084609,0.19579,0.16434,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.012508,0.19555,0.14833,1,1
3,GO TISSUE HOMEOSTASIS,0.0014738,0.19554,0.13904,1,1
3,GO MONOCYTE CHEMOTAXIS,0.046579,0.19528,0.12244,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.00042998,0.1952,0.19521,1,1
3,GO DOPAMINE TRANSPORT,0.0064317,0.19519,0.31045,1,1
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.031059,0.19512,0.12991,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.016734,0.19491,0.15122,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.0028141,0.19483,0.19748,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0051916,0.19479,0.21913,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0032441,0.19456,0.21585,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.0014299,0.19451,0.16488,1,1
3,GO T CELL ACTIVATION,0.0016129,0.19442,0.1488,1,1
3,GO B CELL DIFFERENTIATION,0.00019753,0.19408,0.16414,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.046579,0.194,0.14217,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0010206,0.19396,0.17996,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0028957,0.19394,0.15021,1,1
3,GO MEMBRANE FUSION,0.0028957,0.19393,0.14365,1,1
3,GO BROWN FAT CELL DIFFERENTIATION,0.0020453,0.19325,0.22422,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00092958,0.19309,0.18332,1,1
3,GO ENDOCYTIC RECYCLING,0.0029794,0.19294,0.14412,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0026572,0.19277,0.22713,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0041716,0.19266,0.13618,1,1
3,GO PROGRAMMED NECROTIC CELL DEATH,0.001191,0.19254,0.23266,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.036164,0.19253,0.10937,1,1
3,GO STEROL TRANSPORT,0.0027346,0.19243,0.16462,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0046564,0.1923,0.13337,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0062634,0.19192,0.15367,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.020205,0.19146,0.12267,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00016595,0.19141,0.18441,1,1
3,GO NEUTROPHIL MIGRATION,0.0017641,0.19139,0.13966,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0027346,0.19136,0.16195,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0041716,0.19128,0.12407,1,1
3,GO ENDOCRINE PROCESS,0.026586,0.19126,0.13702,1,1
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.009256,0.19106,0.23896,1,1
3,GO INFLAMMATORY RESPONSE,0.0011549,0.19092,0.15506,1,1
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0034322,0.19077,0.20239,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0094949,0.19066,0.19139,1,1
3,GO RESPONSE TO STEROL,0.0064317,0.19064,0.163,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0021689,0.19063,0.19779,1,1
3,GO B CELL ACTIVATION,0.00028792,0.19044,0.17336,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.0021689,0.19027,0.15578,1,1
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00017796,0.1901,0.20526,1,1
3,GO FATTY ACID CATABOLIC PROCESS,0.0028141,0.18974,0.15089,1,1
3,GO EATING BEHAVIOR,0.00353,0.18964,0.17069,1,1
3,GO CATECHOLAMINE UPTAKE,0.018398,0.18934,0.21523,1,1
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.031748,0.18926,0.16799,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0030654,0.18881,0.15146,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00353,0.18875,0.16609,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0024367,0.18857,0.13645,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,6.2786e-05,0.18848,0.16383,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,0.0007696,0.1883,0.1725,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.02166,0.18814,0.11903,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00047456,0.18812,0.16482,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0060989,0.18798,0.18408,1,1
3,GO MANNOSYLATION,0.00021909,0.18788,0.19447,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00017186,0.18776,0.17877,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.025994,0.18776,0.13942,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00036427,0.18737,0.20916,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.007729,0.18732,0.18924,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0038387,0.1873,0.11973,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION,0.0015189,0.18712,0.15631,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.014841,0.18699,0.25659,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0022332,0.18686,0.1395,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0051916,0.18636,0.15874,1,1
3,GO RENAL TUBULE DEVELOPMENT,0.013139,0.18606,0.12392,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0051916,0.186,0.1812,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.0054795,0.18572,0.14084,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0090226,0.18504,0.13259,1,1
3,GO PLATELET ACTIVATION,0.0034322,0.18493,0.15244,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00057693,0.18485,0.15284,1,1
3,GO HUMORAL IMMUNE RESPONSE,0.00012964,0.18482,0.17617,1,1
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.033894,0.18457,0.10472,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0013457,0.18424,0.13543,1,1
3,GO REGULATION OF CELL ACTIVATION,0.0057817,0.18403,0.1248,1,1
3,GO AMINOGLYCAN METABOLIC PROCESS,0.018836,0.18393,0.13271,1,1
3,GO CYTOKINE SECRETION,0.00054072,0.18391,0.17693,1,1
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0028957,0.18383,0.16596,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.00016595,0.18382,0.23276,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0097392,0.18363,0.12634,1,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00079435,0.18348,0.13919,1,1
3,GO DEVELOPMENTAL INDUCTION,0.0023671,0.18345,0.17963,1,1
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.014138,0.18343,0.16936,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,0.0027346,0.18338,0.13138,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.043763,0.18328,0.1293,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00013433,0.18326,0.21668,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.0066042,0.18268,0.14308,1,1
3,GO ACTIN NUCLEATION,0.00030804,0.18267,0.18146,1,1
3,GO PEPTIDE SECRETION,0.00038934,0.18234,0.15511,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00069957,0.18234,0.15785,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00353,0.18228,0.18546,1,1
3,GO CELLULAR RESPONSE TO VIRUS,0.019283,0.18221,0.11811,1,1
3,GO CARBOHYDRATE TRANSPORT,0.00010845,0.18215,0.16186,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0006154,0.18195,0.18953,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00081984,0.18139,0.14924,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.01282,0.18122,0.19113,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.001872,0.18097,0.19665,1,1
3,GO LYMPHOCYTE ACTIVATION,0.0036303,0.18095,0.12205,1,1
3,GO INOSITOL METABOLIC PROCESS,0.026586,0.18089,0.15603,1,1
3,GO PIGMENTATION,0.0032441,0.18048,0.11714,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,0.00087311,0.18048,0.18935,1,1
3,GO HEART TRABECULA MORPHOGENESIS,0.041093,0.18044,0.12171,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.02166,0.17992,0.16306,1,1
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00012512,0.17981,0.20792,1,1
3,GO RETINOL METABOLIC PROCESS,0.01282,0.17961,0.15709,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0081404,0.17937,0.2095,1,1
3,GO EXOCYTOSIS,0.0013054,0.17875,0.14404,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.00090094,0.17868,0.13545,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0073363,0.17856,0.15942,1,1
3,GO SODIUM ION HOMEOSTASIS,0.0041716,0.17848,0.16933,1,1
3,GO TRANSCYTOSIS,0.023205,0.17829,0.13523,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.001986,0.17822,0.18082,1,1
3,GO MUSCLE ADAPTATION,0.0046564,0.17813,0.14524,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00353,0.17707,0.14022,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0085714,0.17705,0.14781,1,1
3,GO CELL ACTIVATION,0.0024367,0.1767,0.137,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0007696,0.17662,0.12732,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0018173,0.17641,0.15139,1,1
3,GO DEFENSE RESPONSE TO FUNGUS,0.0021062,0.17639,0.157,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.007729,0.17635,0.13969,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00014418,0.17625,0.15508,1,1
3,GO REGULATION OF PEPTIDE SECRETION,0.00014418,0.17619,0.15973,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0071468,0.17585,0.16361,1,1
3,GO RESPONSE TO MECHANICAL STIMULUS,0.00055855,0.17573,0.18041,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.0042883,0.17535,0.12638,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,0.024846,0.17459,0.14299,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0029794,0.17447,0.1646,1,1
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.017549,0.17431,0.18447,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.0085714,0.1743,0.17873,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.0040578,0.17405,0.14167,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.001191,0.17372,0.16393,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.0097392,0.17348,0.14384,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.011047,0.17337,0.13793,1,1
3,GO VESICLE TARGETING,0.023205,0.17319,0.10354,1,1
3,GO REGULATION OF CELL ADHESION,0.009256,0.17311,0.12958,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.011326,0.17308,0.15217,1,1
3,GO HORMONE TRANSPORT,0.0010528,0.17295,0.15964,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.011612,0.17289,0.10214,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.018836,0.17287,0.099371,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.015203,0.17275,0.12317,1,1
3,GO NEUTROPHIL CHEMOTAXIS,0.0024367,0.17258,0.12444,1,1
3,GO RESPONSE TO ALKALOID,0.0054795,0.17249,0.1405,1,1
3,GO REGULATION OF HEMOPOIESIS,0.0014738,0.17241,0.12536,1,1
3,GO STRIATED MUSCLE ADAPTATION,0.011047,0.17193,0.17202,1,1
3,GO CELL CELL ADHESION,0.014138,0.17169,0.12513,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.0045306,0.17133,0.13787,1,1
3,GO RENAL SYSTEM PROCESS,0.02268,0.17117,0.11314,1,1
3,GO RESPONSE TO GONADOTROPIN,0.018398,0.17104,0.14338,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0075304,0.17102,0.12031,1,1
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.03245,0.17102,0.13144,1,1
3,GO INSULIN SECRETION,0.0024367,0.17085,0.15307,1,1
3,GO REGULATION OF PH,0.00016023,0.17051,0.13024,1,1
3,GO VACUOLE ORGANIZATION,9.7346e-05,0.1705,0.15171,1,1
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0031536,0.16985,0.15634,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0046564,0.16977,0.11531,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0079323,0.16972,0.26148,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0090226,0.16966,0.11322,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0015653,0.16956,0.13622,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.03939,0.16946,0.12453,1,1
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.024846,0.16945,0.18246,1,1
3,GO CHOLESTEROL STORAGE,0.015574,0.16938,0.17327,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00019079,0.16937,0.20672,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00026903,0.16933,0.138,1,1
3,GO RESPONSE TO FUNGUS,0.00021167,0.16914,0.17463,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.036948,0.16905,0.11352,1,1
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.018398,0.16866,0.17502,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0037331,0.16856,0.13972,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00095906,0.16832,0.17651,1,1
3,GO T CELL DIFFERENTIATION,0.0013872,0.16816,0.12894,1,1
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.025414,0.16728,0.13642,1,1
3,GO REGULATION OF IMMUNE RESPONSE,0.0038387,0.16716,0.125,1,1
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0018173,0.16708,0.15457,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.040234,0.1669,0.11136,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.02068,0.16684,0.11426,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0046564,0.16677,0.18224,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0059384,0.16662,0.1804,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0013054,0.16653,0.14853,1,1
3,GO PROTEIN N LINKED GLYCOSYLATION,0.00079435,0.16637,0.17957,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,9.0551e-05,0.16609,0.15582,1,1
3,GO ALCOHOL METABOLIC PROCESS,0.001191,0.16594,0.13332,1,1
3,GO TRANSMISSION OF NERVE IMPULSE,0.012508,0.16574,0.21058,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0099891,0.16562,0.14705,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.0022992,0.16545,0.14845,1,1
3,GO REGULATION OF HORMONE LEVELS,0.00090094,0.16544,0.14658,1,1
3,GO VASCULAR WOUND HEALING,0.0097392,0.16522,0.30025,1,1
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0066042,0.16512,0.1754,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.0045306,0.16495,0.24241,1,1
3,GO EPITHELIUM DEVELOPMENT,0.0029794,0.16459,0.11433,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0015653,0.16433,0.16798,1,1
3,GO REGULATION OF DEFENSE RESPONSE,0.00079435,0.16408,0.1468,1,1
3,GO DNA DEMETHYLATION,0.016734,0.16403,0.15393,1,1
3,GO PROTEIN PROCESSING,0.0011549,0.16338,0.15784,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.025994,0.16327,0.13637,1,1
3,GO PEPTIDE HORMONE SECRETION,0.0018173,0.16228,0.15574,1,1
3,GO REGULATION OF VASCULAR PERMEABILITY,0.035393,0.16208,0.14246,1,1
3,GO CELLULAR RESPONSE TO STARVATION,8.4205e-05,0.16187,0.19202,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0016129,0.16184,0.13757,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.001986,0.16143,0.15714,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.01282,0.16141,0.1314,1,1
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.0069616,0.16121,0.16313,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.02166,0.16093,0.12869,1,1
3,GO NECROTIC CELL DEATH,0.0018173,0.16082,0.21734,1,1
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0025083,0.16063,0.15267,1,1
3,GO GOLGI RIBBON FORMATION,0.029068,0.16054,0.12243,1,1
3,GO CELLULAR PIGMENTATION,0.0067808,0.16051,0.11203,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0020453,0.16043,0.15349,1,1
3,GO NEPHRON DEVELOPMENT,0.02843,0.16027,0.096836,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.001872,0.16024,0.11461,1,1
3,GO POSITIVE REGULATION OF SECRETION,0.00034072,0.1602,0.15901,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.023205,0.16019,0.12853,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0027346,0.16004,0.13433,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.02268,0.15974,0.10202,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.00067758,0.15957,0.14492,1,1
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0097392,0.15942,0.18031,1,1
3,GO GOLGI VESICLE BUDDING,0.0031536,0.1591,0.10832,1,1
3,GO WOUND HEALING,0.040234,0.1589,0.088092,1,1
3,GO GLOMERULUS DEVELOPMENT,0.015203,0.15864,0.15557,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.0010859,0.15863,0.17675,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.00041602,0.15849,0.13522,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.013139,0.1584,0.20657,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.00049035,0.15825,0.11561,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.010773,0.15817,0.13432,1,1
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0062634,0.1577,0.15034,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0038387,0.1576,0.14018,1,1
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0073363,0.15742,0.19053,1,1
3,GO PH REDUCTION,0.00054072,0.15719,0.14351,1,1
3,GO REGULATION OF BODY FLUID LEVELS,0.010245,0.15715,0.11485,1,1
3,GO RESPONSE TO BACTERIUM,0.004408,0.15678,0.12977,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.0010206,0.15649,0.11397,1,1
3,GO REGULATION OF T CELL MIGRATION,0.044685,0.15637,0.15729,1,1
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0041716,0.15612,0.14413,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.043763,0.15598,0.11074,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.0039469,0.15596,0.12213,1,1
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.0013457,0.15578,0.13341,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0053338,0.15574,0.13994,1,1
3,GO ER NUCLEUS SIGNALING PATHWAY,0.018398,0.15562,0.13906,1,1
3,GO REGULATION OF CARDIAC CONDUCTION,0.019283,0.15559,0.1293,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.027188,0.1547,0.09858,1,1
3,GO REGULATION OF HORMONE SECRETION,0.0026572,0.15461,0.14358,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,0.00079435,0.15431,0.13214,1,1
3,GO INTERFERON BETA PRODUCTION,0.019283,0.15388,0.1336,1,1
3,GO FLUID TRANSPORT,0.020205,0.15344,0.10857,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0039469,0.15316,0.11823,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0020453,0.15287,0.13305,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0087944,0.15272,0.10763,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00072223,0.15259,0.19891,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0049174,0.15241,0.13074,1,1
3,GO ORGANIC ANION TRANSPORT,0.0017641,0.15227,0.10528,1,1
3,GO REGULATION OF CELLULAR PH,6.5149e-05,0.15199,0.13675,1,1
3,GO RRNA CATABOLIC PROCESS,0.017137,0.15179,0.15172,1,1
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,6.2786e-05,0.15176,0.16927,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,1.349e-05,0.15158,0.15259,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0018173,0.15155,0.13606,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0011549,0.15155,0.16502,1,1
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.046579,0.15147,0.13742,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.0022992,0.15128,0.11372,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0054795,0.15114,0.1267,1,1
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0013457,0.15113,0.19601,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.001191,0.15098,0.17566,1,1
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.013798,0.15093,0.11631,1,1
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0094949,0.15091,0.11431,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.019283,0.15079,0.10476,1,1
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.013139,0.15056,0.12665,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0028141,0.15029,0.12123,1,1
3,GO REGULATION OF BLOOD PRESSURE,0.0051916,0.15012,0.12446,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.043763,0.15009,0.17676,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0024367,0.14996,0.11337,1,1
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.029719,0.14993,0.12028,1,1
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0073363,0.14967,0.2036,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0097392,0.14963,0.1514,1,1
3,GO ADAPTIVE THERMOGENESIS,9.0551e-05,0.14949,0.17846,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.026586,0.14919,0.10418,1,1
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.020205,0.14908,0.12722,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,0.011047,0.14872,0.16092,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0020453,0.14847,0.13664,1,1
3,GO REGULATION OF GLUCONEOGENESIS,0.0025083,0.14846,0.13528,1,1
3,GO LIPID METABOLIC PROCESS,0.0027346,0.14843,0.11338,1,1
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.025994,0.14822,0.11473,1,1
3,GO FAT CELL DIFFERENTIATION,0.0060989,0.14812,0.1488,1,1
3,GO REGULATION OF BLOOD CIRCULATION,0.038561,0.14804,0.097056,1,1
3,GO COPII COATED VESICLE BUDDING,0.0067808,0.14794,0.094581,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.019283,0.14772,0.12169,1,1
3,GO TRANSLESION SYNTHESIS,0.0083534,0.14767,0.11195,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.036948,0.1475,0.17367,1,1
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.025994,0.147,0.13598,1,1
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0027346,0.14696,0.13364,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.0034322,0.14693,0.11685,1,1
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.016339,0.14693,0.12228,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.0025817,0.14543,0.11942,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.007729,0.14537,0.21171,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.038561,0.14501,0.10062,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0015653,0.14478,0.15807,1,1
3,GO GLAND DEVELOPMENT,0.0039469,0.14452,0.11203,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.046579,0.14423,0.11911,1,1
3,GO REGULATION OF CHEMOTAXIS,0.016339,0.14407,0.10524,1,1
3,GO PROTEIN AUTOPROCESSING,0.019739,0.14375,0.14384,1,1
3,GO LIPID HOMEOSTASIS,0.016734,0.14337,0.10222,1,1
3,GO CELL MATURATION,0.0016129,0.14327,0.12854,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0053338,0.14307,0.16313,1,1
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.023741,0.1429,0.15468,1,1
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.010245,0.1428,0.17282,1,1
3,GO SECRETION,0.0021689,0.14267,0.12111,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0081404,0.14266,0.15036,1,1
3,GO REGULATION OF PROTEOLYSIS,0.011904,0.1426,0.094517,1,1
3,GO GPI ANCHOR METABOLIC PROCESS,0.0066042,0.14242,0.16235,1,1
3,GO SENSORY PERCEPTION OF SMELL,0.00065623,0.14236,0.13674,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.010245,0.1423,0.13352,1,1
3,GO REGULATION OF HISTONE DEACETYLATION,0.02166,0.14195,0.15454,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0033369,0.14186,0.21437,1,1
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0085714,0.14179,0.16739,1,1
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.022165,0.14175,0.10801,1,1
3,GO DNA CATABOLIC PROCESS,0.00044439,0.1413,0.13432,1,1
3,GO ORGANELLE FUSION,0.016339,0.141,0.09906,1,1
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.044685,0.14054,0.14807,1,1
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.017137,0.14046,0.17262,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.033894,0.14031,0.097509,1,1
3,GO MANGANESE ION TRANSPORT,0.026586,0.14025,0.10047,1,1
3,GO ANDROGEN METABOLIC PROCESS,0.0069616,0.14019,0.15702,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.033894,0.13988,0.16438,1,1
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016339,0.13977,0.09951,1,1
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.010245,0.1396,0.14402,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.0047853,0.13932,0.13456,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0060989,0.13851,0.1586,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,0.0051916,0.13848,0.10994,1,1
3,GO CHLORIDE TRANSPORT,0.0081404,0.1384,0.11849,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,0.001986,0.1383,0.13067,1,1
3,GO FATTY ACID TRANSPORT,0.037747,0.13825,0.090126,1,1
3,GO CHEMICAL HOMEOSTASIS,0.0021689,0.13802,0.10877,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.035393,0.13776,0.1322,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00084609,0.13773,0.11732,1,1
3,GO RESPONSE TO STARVATION,0.00023468,0.13749,0.17478,1,1
3,GO SODIUM ION TRANSPORT,0.0083534,0.13746,0.13307,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0066042,0.13742,0.24846,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.034637,0.1373,0.12305,1,1
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.01282,0.13706,0.17764,1,1
3,GO PROTEIN DESTABILIZATION,0.0027346,0.13666,0.14258,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0010206,0.13654,0.14152,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00027832,0.13651,0.15223,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0028957,0.13638,0.1444,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0017123,0.13627,0.1174,1,1
3,GO REGULATION OF SECRETION,0.0029794,0.13587,0.11897,1,1
3,GO ACTION POTENTIAL,0.023741,0.13568,0.14317,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.014138,0.13552,0.10708,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.036164,0.13551,0.10245,1,1
3,GO LYSOSOME LOCALIZATION,0.016339,0.13535,0.11945,1,1
3,GO REGULATION OF ANION TRANSPORT,0.0094949,0.13508,0.12766,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.03245,0.13452,0.093164,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0010859,0.13445,0.13596,1,1
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.0036303,0.13428,0.12952,1,1
3,GO RESPONSE TO ISCHEMIA,0.014841,0.13418,0.12263,1,1
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.040234,0.13392,0.090789,1,1
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.02843,0.13374,0.13483,1,1
3,GO ANION TRANSPORT,0.0021689,0.13322,0.099835,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.0087944,0.13283,0.1085,1,1
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.041093,0.13228,0.10088,1,1
3,GO BIOMINERALIZATION,0.016339,0.13209,0.1297,1,1
3,GO RESPONSE TO FATTY ACID,0.042857,0.13185,0.11105,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.013798,0.13172,0.11086,1,1
3,GO ARACHIDONIC ACID SECRETION,0.016734,0.13154,0.13747,1,1
3,GO RESPONSE TO UV C,0.019283,0.1309,0.12306,1,1
3,GO IRON ION TRANSPORT,0.00074557,0.13076,0.11948,1,1
3,GO EPITHELIAL CELL PROLIFERATION,0.042857,0.13036,0.091064,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0079323,0.13023,0.09886,1,1
3,GO T CELL SELECTION,0.0039469,0.13011,0.11596,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.019739,0.1296,0.094801,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0060989,0.12954,0.10698,1,1
3,GO LIPID CATABOLIC PROCESS,0.0016129,0.12937,0.11896,1,1
3,GO REGULATION OF ION TRANSPORT,0.040234,0.12928,0.081858,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.03245,0.12901,0.13308,1,1
3,GO CIRCADIAN RHYTHM,0.00069957,0.12886,0.12925,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0026572,0.12882,0.12499,1,1
3,GO REGULATION OF INSULIN SECRETION,0.0060989,0.12856,0.13096,1,1
3,GO DETECTION OF STIMULUS,0.00065623,0.1285,0.1105,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.020205,0.12832,0.095021,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.011326,0.1282,0.11105,1,1
3,GO TEMPERATURE HOMEOSTASIS,0.00081984,0.12806,0.14623,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.017549,0.12713,0.10827,1,1
3,GO RESPONSE TO DRUG,0.044685,0.12695,0.088668,1,1
3,GO ENDOSOME ORGANIZATION,0.0038387,0.12664,0.10921,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0040578,0.12656,0.13041,1,1
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.024288,0.12648,0.12908,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00353,0.12564,0.18993,1,1
3,GO ORGAN INDUCTION,0.017549,0.12559,0.1108,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0042883,0.12541,0.13972,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.046579,0.12501,0.11679,1,1
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.001872,0.12499,0.12581,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.0010859,0.1249,0.11083,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0099891,0.12489,0.12942,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.035393,0.12452,0.092084,1,1
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.019283,0.12451,0.1298,1,1
3,GO PROTEIN MATURATION,0.0051916,0.12433,0.11076,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0011199,0.1243,0.1295,1,1
3,GO ACID SECRETION,0.02843,0.12428,0.12168,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0016129,0.12402,0.12153,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.02268,0.12326,0.075131,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0022332,0.1231,0.17069,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.011904,0.12302,0.081685,1,1
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02268,0.12301,0.11632,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0090226,0.12276,0.11624,1,1
3,GO CIRCULATORY SYSTEM PROCESS,0.013465,0.1224,0.095474,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0018173,0.12222,0.1038,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.02068,0.12207,0.080806,1,1
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0099891,0.12205,0.081848,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.024846,0.12148,0.075913,1,1
3,GO T CELL LINEAGE COMMITMENT,0.0033369,0.12133,0.13621,1,1
3,GO RESPONSE TO INSULIN,0.0024367,0.12099,0.1181,1,1
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.013798,0.11992,0.11318,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.012508,0.11979,0.1148,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.0031536,0.11957,0.11486,1,1
3,GO METAL ION HOMEOSTASIS,0.0090226,0.11943,0.090441,1,1
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.015574,0.11878,0.1466,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0087944,0.11855,0.13284,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0097392,0.11849,0.093647,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.021165,0.11841,0.13083,1,1
3,GO POSITIVE REGULATION OF JNK CASCADE,0.0064317,0.11836,0.12148,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00047456,0.11805,0.14459,1,1
3,GO RESPONSE TO HORMONE,0.037747,0.11776,0.073183,1,1
3,GO ORGANIC ACID TRANSPORT,0.0069616,0.11744,0.07846,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.011612,0.11723,0.11472,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.015953,0.11686,0.14651,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.014486,0.11683,0.11675,1,1
3,GO PROTEOLYSIS,0.0040578,0.11622,0.084392,1,1
3,GO BONE MINERALIZATION,0.025414,0.11604,0.12451,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.020205,0.11577,0.091807,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.017137,0.11566,0.089757,1,1
3,GO REGULATION OF TOR SIGNALING,0.00010845,0.11548,0.12976,1,1
3,GO VESICLE ORGANIZATION,0.011612,0.11539,0.099519,1,1
3,GO RESPONSE TO CHEMOKINE,0.012203,0.11498,0.10795,1,1
3,GO ENERGY RESERVE METABOLIC PROCESS,0.021165,0.11445,0.12906,1,1
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.022165,0.11443,0.13302,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.034637,0.11417,0.09407,1,1
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.019283,0.11391,0.10936,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.017137,0.11375,0.089579,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.010773,0.1137,0.1011,1,1
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0050528,0.11327,0.12333,1,1
3,GO REGULATION OF CELL DEATH,0.029068,0.11325,0.068066,1,1
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0023671,0.11319,0.16985,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0028957,0.11302,0.10898,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,0.00084609,0.113,0.10969,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0014299,0.11286,0.11383,1,1
3,GO HORMONE METABOLIC PROCESS,0.016339,0.1125,0.12773,1,1
3,GO SARCOMERE ORGANIZATION,0.038561,0.11241,0.10837,1,1
3,GO ION HOMEOSTASIS,0.0099891,0.11198,0.086406,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.017969,0.11198,0.098038,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0029794,0.11192,0.11282,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0075304,0.11106,0.10013,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0022992,0.111,0.10381,1,1
3,GO OXIDATION REDUCTION PROCESS,0.011612,0.11095,0.091224,1,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.044685,0.11047,0.15011,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.033894,0.11037,0.0747,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.027188,0.10982,0.09235,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0081404,0.10951,0.094302,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,0.013139,0.10949,0.10718,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.02068,0.10882,0.10635,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.0047853,0.10835,0.11837,1,1
3,GO RESPONSE TO CALCIUM ION,0.012203,0.10773,0.1374,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0047853,0.10766,0.10494,1,1
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.033894,0.10758,0.10876,1,1
3,GO TRANSITION METAL ION TRANSPORT,0.0030654,0.10737,0.089452,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0051916,0.10717,0.10359,1,1
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.027188,0.10714,0.14167,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.029068,0.10707,0.089309,1,1
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.033166,0.10689,0.094089,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.030383,0.10678,0.11041,1,1
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.029719,0.1055,0.09373,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0032441,0.10526,0.12142,1,1
3,GO TOR SIGNALING,0.00010092,0.10524,0.1049,1,1
3,GO APOPTOTIC PROCESS,0.017969,0.10488,0.072129,1,1
3,GO POSTREPLICATION REPAIR,0.045624,0.10488,0.066554,1,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.022165,0.10389,0.10184,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0032441,0.10314,0.10834,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.02843,0.10258,0.079399,1,1
3,GO PROTEIN AUTOUBIQUITINATION,0.00067758,0.10258,0.10052,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.014138,0.10204,0.088533,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.035393,0.10194,0.074841,1,1
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.025994,0.10176,0.089526,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.013798,0.10164,0.087549,1,1
3,GO LIPID MODIFICATION,0.015953,0.10136,0.087629,1,1
3,GO SIGNAL RELEASE,0.013465,0.10115,0.10877,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0062634,0.10092,0.086663,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.042857,0.10047,0.076077,1,1
3,GO ANATOMICAL STRUCTURE MATURATION,0.015574,0.10019,0.089021,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.029719,0.10009,0.1195,1,1
3,GO RESPONSE TO PEPTIDE,0.036948,0.099986,0.072294,1,1
3,GO ION TRANSPORT,0.0069616,0.099772,0.093232,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.02166,0.098395,0.086818,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.043763,0.098174,0.09606,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.0051916,0.098154,0.10298,1,1
3,GO INORGANIC ANION TRANSPORT,0.0097392,0.098154,0.099251,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.017137,0.09808,0.13728,1,1
3,GO POSITIVE T CELL SELECTION,0.024846,0.097813,0.088104,1,1
3,GO POLYOL CATABOLIC PROCESS,0.010773,0.096915,0.12921,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,0.017549,0.096242,0.083147,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.029719,0.096205,0.079861,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,0.0087944,0.096196,0.097742,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.038561,0.095411,0.067532,1,1
3,GO EXOCYTIC PROCESS,0.045624,0.095397,0.13131,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.045624,0.095393,0.07815,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.027188,0.095072,0.085879,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.017137,0.095011,0.074156,1,1
3,GO HOMEOSTATIC PROCESS,0.0037331,0.094988,0.084623,1,1
3,GO TRANSMEMBRANE TRANSPORT,0.0083534,0.094754,0.083237,1,1
3,GO PEROXISOME ORGANIZATION,0.027803,0.094009,0.097731,1,1
3,GO REGULATION OF OSSIFICATION,0.021165,0.093912,0.11698,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.0085714,0.093813,0.087546,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,0.02166,0.092518,0.071824,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.02268,0.092377,0.073951,1,1
3,GO MYOFIBRIL ASSEMBLY,0.040234,0.091765,0.08171,1,1
3,GO PEROXISOMAL TRANSPORT,0.02268,0.091756,0.1096,1,1
3,GO SENSORY PERCEPTION,0.016734,0.091406,0.071638,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.03939,0.091116,0.059229,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.0019282,0.090983,0.099709,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.022165,0.090048,0.077196,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0046564,0.087999,0.10607,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,0.0079323,0.087897,0.089652,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.019283,0.087895,0.072633,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.02068,0.087843,0.083751,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.023205,0.087732,0.071256,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.029719,0.08537,0.10052,1,1
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.036948,0.084929,0.070012,1,1
3,GO CATION TRANSPORT,0.031748,0.084517,0.076801,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.038561,0.083098,0.078379,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.030383,0.083095,0.093181,1,1
3,GO DENDRITE EXTENSION,0.025994,0.081657,0.23483,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.011047,0.081462,0.095993,1,1
3,GO ENDOSOMAL TRANSPORT,0.0083534,0.081148,0.064312,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.016339,0.080482,0.076212,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0087944,0.079578,0.11458,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.031059,0.078625,0.071065,1,1
3,GO POSITIVE REGULATION OF NEURON DEATH,0.031059,0.078276,0.10517,1,1
3,GO PROTEIN POLYUBIQUITINATION,0.0053338,0.077992,0.072514,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.013465,0.077152,0.081649,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.035393,0.076427,0.077565,1,1
3,GO RHYTHMIC PROCESS,0.036948,0.07599,0.069537,1,1
3,GO CYTOSOLIC TRANSPORT,0.033166,0.075683,0.049324,1,1
3,GO REGULATION OF TRANSPORT,0.027188,0.074921,0.067796,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.026586,0.072968,0.074108,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.02166,0.072573,0.075087,1,1
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.036164,0.070072,0.061013,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.027188,0.070053,0.10007,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.042857,0.069841,0.068245,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.03939,0.069758,0.06302,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,0.02068,0.067387,0.07375,1,1
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.040234,0.06736,0.087542,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.033894,0.066423,0.075795,1,1
3,GO REGULATION OF CIRCADIAN RHYTHM,0.030383,0.064691,0.088434,1,1
3,GO HISTONE H2B UBIQUITINATION,0.025414,0.063589,0.099915,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.025414,0.062684,0.062868,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.044685,0.055313,0.060545,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.025994,0.051496,0.058436,1,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.041093,0.043644,0.086016,1,1
